{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T14:48:07Z","timestamp":1792507687060,"version":"4.5.0"},"reference-count":248,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T00:00:00Z","timestamp":1661385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T00:00:00Z","timestamp":1661385600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["202397\/Z\/16\/Z"],"award-info":[{"award-number":["202397\/Z\/16\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Despite strong evidence of the neurodevelopmental origins of psychosis, current pharmacological treatment is not usually initiated until after a clinical diagnosis is made, and is focussed on antagonising striatal dopamine receptors. These drugs are only partially effective, have serious side effects, fail to alleviate the negative and cognitive symptoms of the disorder, and are not useful as a preventive treatment. In recent years, attention has turned to upstream brain regions that regulate striatal dopamine function, such as the hippocampus. This review draws together these recent data to discuss why the hippocampus may be especially vulnerable in the pathophysiology of psychosis. First, we describe the neurodevelopmental trajectory of the hippocampus and its susceptibility to dysfunction, exploring this region\u2019s proneness to structural and functional imbalances, metabolic pressures, and oxidative stress. We then examine mechanisms of hippocampal dysfunction in psychosis and in individuals at high-risk for psychosis and discuss how and when hippocampal abnormalities may be targeted in these groups. We conclude with future directions for prospective studies to unlock the discovery of novel therapeutic strategies targeting hippocampal circuit imbalances to prevent or delay the onset of psychosis.<\/jats:p>","DOI":"10.1038\/s41398-022-02115-5","type":"journal-article","created":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T10:04:48Z","timestamp":1661421888000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":61,"title":["Hippocampal circuit dysfunction in psychosis"],"prefix":"10.1038","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3420-3722","authenticated-orcid":false,"given":"Samuel","family":"Knight","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1102-2566","authenticated-orcid":false,"given":"Robert","family":"McCutcheon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4931-9007","authenticated-orcid":false,"given":"Daniella","family":"Dwir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony A.","family":"Grace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5690-1252","authenticated-orcid":false,"given":"Owen","family":"O\u2019Daly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4381-0532","authenticated-orcid":false,"given":"Philip","family":"McGuire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7870-066X","authenticated-orcid":false,"given":"Gemma","family":"Modinos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,25]]},"reference":[{"key":"2115_CR1","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1038\/mp.2017.249","volume":"23","author":"JA Lieberman","year":"2018","unstructured":"Lieberman JA, Girgis RR, Brucato G, Moore H, Provenzano F, Kegeles L, et al. Hippocampal dysfunction in the pathophysiology of schizophrenia: a selective review and hypothesis for early detection and intervention. Mol Psychiatry. 2018;23:1764\u201372.","journal-title":"Mol Psychiatry"},{"key":"2115_CR2","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1176\/appi.ajp.2010.09081187","volume":"167","author":"CA Tamminga","year":"2010","unstructured":"Tamminga CA, Stan AD, Wagner AD. The hippocampal formation in schizophrenia. Am J Psychiatry. 2010;167:1178\u201393.","journal-title":"Am J Psychiatry"},{"key":"2115_CR3","doi-asserted-by":"publisher","first-page":"3524","DOI":"10.1038\/s41380-020-0853-y","volume":"26","author":"MJ Roeske","year":"2021","unstructured":"Roeske MJ, Konradi C, Heckers S, Lewis AS. Hippocampal volume and hippocampal neuron density, number and size in schizophrenia: a systematic review and meta-analysis of postmortem studies. Mol Psychiatry. 2021;26:3524\u201335.","journal-title":"Mol Psychiatry"},{"key":"2115_CR4","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/mp.2015.63","volume":"21","author":"TG van Erp","year":"2016","unstructured":"van Erp TG, Hibar DP, Rasmussen JM, Glahn DC, Pearlson GD, Andreassen OA, et al. Subcortical brain volume abnormalities in 2028 individuals with schizophrenia and 2540 healthy controls via the ENIGMA consortium. Mol Psychiatry. 2016;21:547\u201353.","journal-title":"Mol Psychiatry"},{"key":"2115_CR5","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1093\/schbul\/sbs118","volume":"39","author":"SV Haijma","year":"2013","unstructured":"Haijma SV, Van Haren N, Cahn W, Koolschijn PC, Hulshoff Pol HE, Kahn RS. Brain volumes in schizophrenia: a meta-analysis in over 18 000 subjects. Schizophr Bull. 2013;39:1129\u201338.","journal-title":"Schizophr Bull"},{"key":"2115_CR6","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1007\/s11682-017-9721-z","volume":"12","author":"SA Mitelman","year":"2018","unstructured":"Mitelman SA, Bralet MC, Mehmet Haznedar M, Hollander E, Shihabuddin L, Hazlett EA, et al. Positron emission tomography assessment of cerebral glucose metabolic rates in autism spectrum disorder and schizophrenia. Brain Imaging Behav. 2018;12:532\u201346.","journal-title":"Brain Imaging Behav"},{"key":"2115_CR7","doi-asserted-by":"publisher","first-page":"278","DOI":"10.3389\/fpsyt.2020.00278","volume":"11","author":"EK Edmiston","year":"2020","unstructured":"Edmiston EK, Song Y, Chang M, Yin Z, Zhou Q, Zhou Y, et al. Hippocampal resting state functional connectivity in patients with schizophrenia and unaffected family members. Front Psychiatry. 2020;11:278.","journal-title":"Front Psychiatry"},{"key":"2115_CR8","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jpsychires.2021.03.041","volume":"138","author":"SS Gangadin","year":"2021","unstructured":"Gangadin SS, Cahn W, Scheewe TW, Hulshoff Pol HE, Bossong MG. Reduced resting state functional connectivity in the hippocampus-midbrain-striatum network of schizophrenia patients. J Psychiatr Res. 2021;138:83\u20138.","journal-title":"J Psychiatr Res"},{"key":"2115_CR9","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.pscychresns.2015.06.004","volume":"233","author":"N Samudra","year":"2015","unstructured":"Samudra N, Ivleva EI, Hubbard NA, Rypma B, Sweeney JA, Clementz BA, et al. Alterations in hippocampal connectivity across the psychosis dimension. Psychiatry Res. 2015;233:148\u201357.","journal-title":"Psychiatry Res"},{"key":"2115_CR10","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1176\/appi.ajp.2013.13070981","volume":"171","author":"JR Tregellas","year":"2014","unstructured":"Tregellas JR, Smucny J, Harris JG, Olincy A, Maharajh K, Kronberg E, et al. Intrinsic hippocampal activity as a biomarker for cognition and symptoms in schizophrenia. Am J Psychiatry. 2014;171:549\u201356.","journal-title":"Am J Psychiatry"},{"key":"2115_CR11","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1176\/appi.ajp.2019.19020151","volume":"176","author":"M McHugo","year":"2019","unstructured":"McHugo M, Talati P, Armstrong K, Vandekar SN, Blackford JU, Woodward ND, et al. Hyperactivity and reduced activation of anterior hippocampus in early psychosis. Am J Psychiatry. 2019;176:1030\u20138.","journal-title":"Am J Psychiatry"},{"key":"2115_CR12","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1001\/archgenpsychiatry.2009.115","volume":"66","author":"SA Schobel","year":"2009","unstructured":"Schobel SA, Lewandowski NM, Corcoran CM, Moore H, Brown T, Malaspina D, et al. Differential targeting of the CA1 subfield of the hippocampal formation by schizophrenia and related psychotic disorders. Arch Gen Psychiatry. 2009;66:938\u201346.","journal-title":"Arch Gen Psychiatry"},{"key":"2115_CR13","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.pscychresns.2015.03.007","volume":"232","author":"P Talati","year":"2015","unstructured":"Talati P, Rane S, Skinner J, Gore J, Heckers S. Increased hippocampal blood volume and normal blood flow in schizophrenia. Psychiatry Res. 2015;232:219\u201325.","journal-title":"Psychiatry Res"},{"key":"2115_CR14","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1093\/schbul\/sbx169","volume":"44","author":"P Allen","year":"2018","unstructured":"Allen P, Azis M, Modinos G, Bossong MG, Bonoldi I, Samson C, et al. Increased resting hippocampal and basal ganglia perfusion in people at ultra high risk for psychosis: replication in a second cohort. Schizophr Bull. 2018;44:1323\u201331.","journal-title":"Schizophr Bull"},{"key":"2115_CR15","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1176\/appi.ajp.2015.15040485","volume":"173","author":"P Allen","year":"2016","unstructured":"Allen P, Chaddock CA, Egerton A, Howes OD, Bonoldi I, Zelaya F, et al. Resting hyperperfusion of the hippocampus, midbrain, and basal ganglia in people at high risk for psychosis. Am J Psychiatry. 2016;173:392\u20139.","journal-title":"Am J Psychiatry"},{"key":"2115_CR16","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1001\/jamapsychiatry.2019.3501","volume":"77","author":"G Modinos","year":"2020","unstructured":"Modinos G, Kempton MJ, Tognin S, Calem M, Porffy L, Antoniades M, et al. Association of adverse outcomes with emotion processing and its neural substrate in individuals at clinical high risk for psychosis. JAMA Psychiatry. 2020;77:190\u2013200.","journal-title":"JAMA Psychiatry"},{"key":"2115_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2017.174","volume":"7","author":"T Winton-Brown","year":"2017","unstructured":"Winton-Brown T, Schmidt A, Roiser JP, Howes OD, Egerton A, Fusar-Poli P, et al. Altered activation and connectivity in a hippocampal-basal ganglia-midbrain circuit during salience processing in subjects at ultra high risk for psychosis. Transl Psychiatry. 2017;7:e1245.","journal-title":"Transl Psychiatry"},{"key":"2115_CR18","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1093\/schbul\/sbp113","volume":"37","author":"P Allen","year":"2011","unstructured":"Allen P, Seal ML, Valli I, Fusar-Poli P, Perlini C, Day F, et al. Altered prefrontal and hippocampal function during verbal encoding and recognition in people with prodromal symptoms of psychosis. Schizophr Bull. 2011;37:746\u201356.","journal-title":"Schizophr Bull"},{"key":"2115_CR19","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.tips.2011.05.001","volume":"32","author":"DJ Lodge","year":"2011","unstructured":"Lodge DJ, Grace AA. Hippocampal dysregulation of dopamine system function and the pathophysiology of schizophrenia. Trends Pharm Sci. 2011;32:507\u201313.","journal-title":"Trends Pharm Sci"},{"key":"2115_CR20","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1093\/schbul\/sbx199","volume":"45","author":"AA Grace","year":"2019","unstructured":"Grace AA, Gomes FV. The circuitry of dopamine system regulation and its disruption in schizophrenia: insights into treatment and prevention. Schizophr Bull. 2019;45:148\u201357.","journal-title":"Schizophr Bull"},{"key":"2115_CR21","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/j.tics.2018.07.006","volume":"22","author":"G Buzsaki","year":"2018","unstructured":"Buzsaki G, Tingley D. Space and time: the hippocampus as a sequence generator. Trends Cogn Sci. 2018;22:853\u201369.","journal-title":"Trends Cogn Sci"},{"key":"2115_CR22","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.neuron.2018.10.002","volume":"100","author":"TEJ Behrens","year":"2018","unstructured":"Behrens TEJ, Muller TH, Whittington JCR, Mark S, Baram AB, Stachenfeld KL, et al. What is a cognitive map? Organizing knowledge for flexible behavior. Neuron. 2018;100:490\u2013509.","journal-title":"Neuron"},{"key":"2115_CR23","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.cell.2019.06.012","volume":"178","author":"Y Liu","year":"2019","unstructured":"Liu Y, Dolan RJ, Kurth-Nelson Z, Behrens TEJ. Human replay spontaneously reorganizes experience. Cell. 2019;178:640\u201352.e614.","journal-title":"Cell"},{"key":"2115_CR24","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/s41537-022-00247-7","volume":"8","author":"A Musa","year":"2022","unstructured":"Musa A, Khan S, Mujahid M, El-Gaby M. The shallow cognitive map hypothesis: A hippocampal framework for thought disorder in schizophrenia. Schizophrenia. 2022;8:34.","journal-title":"Schizophrenia"},{"key":"2115_CR25","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.neuron.2015.12.008","volume":"89","author":"JC Silbereis","year":"2016","unstructured":"Silbereis JC, Pochareddy S, Zhu Y, Li M, Sestan N. The cellular and molecular landscapes of the developing human central nervous system. Neuron. 2016;89:248\u201368.","journal-title":"Neuron"},{"key":"2115_CR26","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1038\/nrn1787","volume":"6","author":"TK Hensch","year":"2005","unstructured":"Hensch TK. Critical period plasticity in local cortical circuits. Nat Rev Neurosci. 2005;6:877\u201388.","journal-title":"Nat Rev Neurosci"},{"key":"2115_CR27","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/nrn.2018.1","volume":"19","author":"JH Gilmore","year":"2018","unstructured":"Gilmore JH, Knickmeyer RC, Gao W. Imaging structural and functional brain development in early childhood. Nat Rev Neurosci. 2018;19:123\u201337.","journal-title":"Nat Rev Neurosci"},{"key":"2115_CR28","doi-asserted-by":"publisher","first-page":"13281","DOI":"10.1073\/pnas.1105108108","volume":"108","author":"Z Petanjek","year":"2011","unstructured":"Petanjek Z, Judas M, Simic G, Rasin MR, Uylings HB, Rakic P, et al. Extraordinary neoteny of synaptic spines in the human prefrontal cortex. Proc Natl Acad Sci USA. 2011;108:13281\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2115_CR29","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1002\/(SICI)1096-9861(19971020)387:2<167::AID-CNE1>3.0.CO;2-Z","volume":"387","author":"PR Huttenlocher","year":"1997","unstructured":"Huttenlocher PR, Dabholkar AS. Regional differences in synaptogenesis in human cerebral cortex. J Comp Neurol. 1997;387:167\u201378.","journal-title":"J Comp Neurol"},{"key":"2115_CR30","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1159\/000096222","volume":"29","author":"P Lavenex","year":"2007","unstructured":"Lavenex P, Banta Lavenex P, Amaral DG. Postnatal development of the primate hippocampal formation. Dev Neurosci. 2007;29:179\u201392.","journal-title":"Dev Neurosci"},{"key":"2115_CR31","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.neuroimage.2016.07.044","volume":"141","author":"KL Mills","year":"2016","unstructured":"Mills KL, Goddings AL, Herting MM, Meuwese R, Blakemore SJ, Crone EA, et al. Structural brain development between childhood and adulthood: Convergence across four longitudinal samples. Neuroimage. 2016;141:273\u201381.","journal-title":"Neuroimage"},{"key":"2115_CR32","doi-asserted-by":"publisher","unstructured":"Backhausen LL, Fr\u00f6hner JH, Lema\u00eetre H, Artiges E, Palill\u00e8re Martinot M-L, Herting MM, et al. Adolescent to young adult longitudinal development of subcortical volumes in two European sites with four waves. bioRxiv. 2021; https:\/\/doi.org\/10.1101\/2021.06.09.447677.","DOI":"10.1101\/2021.06.09.447677"},{"key":"2115_CR33","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.neuroimage.2018.01.020","volume":"172","author":"MM Herting","year":"2018","unstructured":"Herting MM, Johnson C, Mills KL, Vijayakumar N, Dennison M, Liu C, et al. Development of subcortical volumes across adolescence in males and females: A multisample study of longitudinal changes. Neuroimage. 2018;172:194\u2013205.","journal-title":"Neuroimage"},{"key":"2115_CR34","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.neuroimage.2014.03.072","volume":"96","author":"L Wierenga","year":"2014","unstructured":"Wierenga L, Langen M, Ambrosino S, van Dijk S, Oranje B, Durston S. Typical development of basal ganglia, hippocampus, amygdala and cerebellum from age 7 to 24. Neuroimage. 2014;96:67\u201372.","journal-title":"Neuroimage"},{"key":"2115_CR35","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/nature25975","volume":"555","author":"SF Sorrells","year":"2018","unstructured":"Sorrells SF, Paredes MF, Cebrian-Silla A, Sandoval K, Qi D, Kelley KW, et al. Human hippocampal neurogenesis drops sharply in children to undetectable levels in adults. Nature. 2018;555:377\u201381.","journal-title":"Nature"},{"key":"2115_CR36","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.stem.2018.03.015","volume":"22","author":"M Boldrini","year":"2018","unstructured":"Boldrini M, Fulmore CA, Tartt AN, Simeon LR, Pavlova I, Poposka V, et al. Human hippocampal neurogenesis persists throughout aging. Cell Stem Cell. 2018;22:589\u201399.e585.","journal-title":"Cell Stem Cell"},{"key":"2115_CR37","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.stem.2018.04.004","volume":"23","author":"G Kempermann","year":"2018","unstructured":"Kempermann G, Gage FH, Aigner L, Song H, Curtis MA, Thuret S, et al. Human adult neurogenesis: evidence and remaining questions. Cell Stem Cell. 2018;23:25\u201330.","journal-title":"Cell Stem Cell"},{"key":"2115_CR38","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1038\/sj.mp.4001791","volume":"11","author":"A Reif","year":"2006","unstructured":"Reif A, Fritzen S, Finger M, Strobel A, Lauer M, Schmitt A, et al. Neural stem cell proliferation is decreased in schizophrenia, but not in depression. Mol Psychiatry. 2006;11:514\u201322.","journal-title":"Mol Psychiatry"},{"key":"2115_CR39","doi-asserted-by":"publisher","first-page":"e13007","DOI":"10.1111\/acel.13007","volume":"18","author":"DA Kozareva","year":"2019","unstructured":"Kozareva DA, Cryan JF, Nolan YM. Born this way: Hippocampal neurogenesis across the lifespan. Aging Cell. 2019;18:e13007.","journal-title":"Aging Cell"},{"key":"2115_CR40","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1002\/hipo.20193","volume":"16","author":"N Gogtay","year":"2006","unstructured":"Gogtay N, Nugent TF 3rd, Herman DH, Ordonez A, Greenstein D, Hayashi KM, et al. Dynamic mapping of normal human hippocampal development. Hippocampus. 2006;16:664\u201372.","journal-title":"Hippocampus"},{"key":"2115_CR41","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1093\/schbul\/sbn101","volume":"34","author":"R van Winkel","year":"2008","unstructured":"van Winkel R, Stefanis NC, Myin-Germeys I. Psychosocial stress and psychosis. A review of the neurobiological mechanisms and the evidence for gene-stress interaction. Schizophr Bull. 2008;34:1095\u2013105.","journal-title":"Schizophr Bull"},{"key":"2115_CR42","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.biopsych.2013.02.016","volume":"74","author":"EF Walker","year":"2013","unstructured":"Walker EF, Trotman HD, Pearce BD, Addington J, Cadenhead KS, Cornblatt BA, et al. Cortisol levels and risk for psychosis: initial findings from the North American prodrome longitudinal study. Biol Psychiatry. 2013;74:410\u20137.","journal-title":"Biol Psychiatry"},{"key":"2115_CR43","doi-asserted-by":"publisher","first-page":"2382","DOI":"10.1093\/brain\/awu132","volume":"137","author":"NA Crossley","year":"2014","unstructured":"Crossley NA, Mechelli A, Scott J, Carletti F, Fox PT, McGuire P, et al. The hubs of the human connectome are generally implicated in the anatomy of brain disorders. Brain. 2014;137:2382\u201395.","journal-title":"Brain"},{"key":"2115_CR44","doi-asserted-by":"publisher","first-page":"15775","DOI":"10.1523\/JNEUROSCI.3539-11.2011","volume":"31","author":"MP van den Heuvel","year":"2011","unstructured":"van den Heuvel MP, Sporns O. Rich-club organization of the human connectome. J Neurosci. 2011;31:15775\u201386.","journal-title":"J Neurosci"},{"key":"2115_CR45","doi-asserted-by":"publisher","first-page":"3378","DOI":"10.1111\/ejn.15213","volume":"53","author":"L Ezama","year":"2021","unstructured":"Ezama L, Hernandez-Cabrera JA, Seoane S, Pereda E, Janssen N. Functional connectivity of the hippocampus and its subfields in resting-state networks. Eur J Neurosci. 2021;53:3378\u201393.","journal-title":"Eur J Neurosci"},{"key":"2115_CR46","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1002\/hbm.23353","volume":"38","author":"SL Blankenship","year":"2017","unstructured":"Blankenship SL, Redcay E, Dougherty LR, Riggins T. Development of hippocampal functional connectivity during childhood. Hum Brain Mapp. 2017;38:182\u2013201.","journal-title":"Hum Brain Mapp"},{"key":"2115_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-020-00985-1","volume":"10","author":"M McHugo","year":"2020","unstructured":"McHugo M, Armstrong K, Roeske MJ, Woodward ND, Blackford JU, Heckers S. Hippocampal volume in early psychosis: a 2-year longitudinal study. Transl Psychiatry. 2020;10:306.","journal-title":"Transl Psychiatry"},{"key":"2115_CR48","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1093\/schbul\/sbx160","volume":"44","author":"T Vargas","year":"2018","unstructured":"Vargas T, Dean DJ, Osborne KJ, Gupta T, Ristanovic I, Ozturk S, et al. Hippocampal subregions across the psychosis spectrum. Schizophr Bull. 2018;44:1091\u20139.","journal-title":"Schizophr Bull"},{"key":"2115_CR49","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1080\/15622975.2016.1199893","volume":"17","author":"M Hyza","year":"2016","unstructured":"Hyza M, Kuhn M, Ceskova E, Ustohal L, Kasparek T. Hippocampal volume in first-episode schizophrenia and longitudinal course of the illness. World J Biol Psychiatry. 2016;17:429\u201338.","journal-title":"World J Biol Psychiatry"},{"key":"2115_CR50","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1002\/hbm.25045","volume":"43","author":"P Kochunov","year":"2022","unstructured":"Kochunov P, Fan F, Ryan MC, Hatch KS, Tan S, Jahanshad N, et al. Translating ENIGMA schizophrenia findings using the regional vulnerability index: association with cognition, symptoms, and disease trajectory. Hum Brain Mapp. 2022;43:566\u201375.","journal-title":"Hum Brain Mapp"},{"key":"2115_CR51","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1177\/1073858410395147","volume":"18","author":"F Adriano","year":"2012","unstructured":"Adriano F, Caltagirone C, Spalletta G. Hippocampal volume reduction in first-episode and chronic schizophrenia: a review and meta-analysis. Neuroscientist. 2012;18:180\u2013200.","journal-title":"Neuroscientist"},{"key":"2115_CR52","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.neuron.2013.02.011","volume":"78","author":"SA Schobel","year":"2013","unstructured":"Schobel SA, Chaudhury NH, Khan UA, Paniagua B, Styner MA, Asllani I, et al. Imaging patients with psychosis and a mouse model establishes a spreading pattern of hippocampal dysfunction and implicates glutamate as a driver. Neuron. 2013;78:81\u201393.","journal-title":"Neuron"},{"key":"2115_CR53","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1038\/s41386-021-01019-0","volume":"46","author":"G Modinos","year":"2021","unstructured":"Modinos G, Richter A, Egerton A, Bonoldi I, Azis M, Antoniades M, et al. Interactions between hippocampal activity and striatal dopamine in people at clinical high risk for psychosis: relationship to adverse outcomes. Neuropsychopharmacology. 2021;46:1468\u201374.","journal-title":"Neuropsychopharmacology"},{"key":"2115_CR54","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1016\/j.neubiorev.2016.10.007","volume":"71","author":"A Walter","year":"2016","unstructured":"Walter A, Suenderhauf C, Harrisberger F, Lenz C, Smieskova R, Chung Y, et al. Hippocampal volume in subjects at clinical high-risk for psychosis: A systematic review and meta-analysis. Neurosci Biobehav Rev. 2016;71:680\u201390.","journal-title":"Neurosci Biobehav Rev"},{"key":"2115_CR55","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1001\/jamapsychiatry.2021.0638","volume":"78","author":"M Jalbrzikowski","year":"2021","unstructured":"Group ECHRfPW, Jalbrzikowski M, Hayes RA, Wood SJ, Nordholm D, Zhou JH, et al. Association of structural magnetic resonance imaging measures with psychosis onset in individuals at clinical high risk for developing psychosis: an ENIGMA Working Group Mega-analysis. JAMA Psychiatry. 2021;78:753\u201366.","journal-title":"JAMA Psychiatry"},{"key":"2115_CR56","doi-asserted-by":"publisher","first-page":"642048","DOI":"10.3389\/fpsyt.2021.642048","volume":"12","author":"D Sasabayashi","year":"2021","unstructured":"Sasabayashi D, Yoshimura R, Takahashi T, Takayanagi Y, Nishiyama S, Higuchi Y, et al. Reduced hippocampal subfield volume in schizophrenia and clinical high-risk state for psychosis. Front Psychiatry. 2021;12:642048.","journal-title":"Front Psychiatry"},{"key":"2115_CR57","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1001\/archgenpsychiatry.2011.42","volume":"68","author":"A Mechelli","year":"2011","unstructured":"Mechelli A, Riecher-R\u00f6ssler A, Meisenzahl EM, Tognin S, Wood SJ, Borgwardt SJ, et al. Neuroanatomical abnormalities that predate the onset of psychosis: a multicenter study. Arch Gen Psychiatry. 2011;68:489\u201395.","journal-title":"Arch Gen Psychiatry"},{"key":"2115_CR58","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0140-6736(03)12323-9","volume":"361","author":"C Pantelis","year":"2003","unstructured":"Pantelis C, Velakoulis D, McGorry PD, Wood SJ, Suckling J, Phillips LJ, et al. Neuroanatomical abnormalities before and after onset of psychosis: a cross-sectional and longitudinal MRI comparison. Lancet. 2003;361:281\u20138.","journal-title":"Lancet"},{"key":"2115_CR59","doi-asserted-by":"publisher","first-page":"614659","DOI":"10.3389\/fpsyt.2020.614659","volume":"11","author":"B Hinney","year":"2020","unstructured":"Hinney B, Walter A, Aghlmandi S, Andreou C, Borgwardt S. Does hippocampal volume predict transition to psychosis in a high-risk group? A Meta-Analysis. Front Psychiatry. 2020;11:614659.","journal-title":"Front Psychiatry"},{"key":"2115_CR60","unstructured":"Tognin S, Richter A, Kempton MJ, Modinos G, Antoniades M, Azis M, et al. The relationship between grey matter volume and clinical and functional outcomes in people at clinical high risk for psychosis. Schizophrenia Bulletin Open. 2022;sgac040."},{"key":"2115_CR61","doi-asserted-by":"publisher","first-page":"e0233670","DOI":"10.1371\/journal.pone.0233670","volume":"15","author":"A Calvo","year":"2020","unstructured":"Calvo A, Roddy DW, Coughlan H, Kelleher I, Healy C, Harley M, et al. Reduced hippocampal volume in adolescents with psychotic experiences: A longitudinal population-based study. PLoS ONE. 2020;15:e0233670.","journal-title":"PLoS ONE"},{"key":"2115_CR62","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1001\/jamapsychiatry.2015.3463","volume":"73","author":"TD Satterthwaite","year":"2016","unstructured":"Satterthwaite TD, Wolf DH, Calkins ME, Vandekar SN, Erus G, Ruparel K, et al. Structural brain abnormalities in youth with psychosis spectrum symptoms. JAMA Psychiatry. 2016;73:515\u201324.","journal-title":"JAMA Psychiatry"},{"key":"2115_CR63","doi-asserted-by":"publisher","first-page":"4055","DOI":"10.1002\/hbm.24231","volume":"39","author":"G Modinos","year":"2018","unstructured":"Modinos G, Egerton A, McMullen K, McLaughlin A, Kumari V, Barker GJ, et al. Increased resting perfusion of the hippocampus in high positive schizotypy: a pseudocontinuous arterial spin labeling study. Hum Brain Mapp. 2018;39:4055\u201364.","journal-title":"Hum Brain Mapp"},{"key":"2115_CR64","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-020-01131-7","volume":"11","author":"J Schoorl","year":"2021","unstructured":"Schoorl J, Barbu MC, Shen X, Harris MR, Adams MJ, Whalley HC, et al. Grey and white matter associations of psychotic-like experiences in a general population sample (UK Biobank). Transl Psychiatry. 2021;11:21.","journal-title":"Transl Psychiatry"},{"key":"2115_CR65","doi-asserted-by":"publisher","unstructured":"Brosch K, Stein F, Schmitt S, Pfarr JK, Ringwald KG, Thomas-Odenthal F, et al. Reduced hippocampal gray matter volume is a common feature of patients with major depression, bipolar disorder, and schizophrenia spectrum disorders. Mol Psychiatry. 2022; https:\/\/doi.org\/10.1038\/s41380-022-01687-4.","DOI":"10.1038\/s41380-022-01687-4"},{"key":"2115_CR66","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1001\/jamapsychiatry.2014.2206","volume":"72","author":"M Goodkind","year":"2015","unstructured":"Goodkind M, Eickhoff SB, Oathes DJ, Jiang Y, Chang A, Jones-Hagata LB, et al. Identification of a common neurobiological substrate for mental illness. JAMA Psychiatry. 2015;72:305\u201315.","journal-title":"JAMA Psychiatry"},{"key":"2115_CR67","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1038\/s41380-020-01002-z","volume":"26","author":"NV Radonjic","year":"2021","unstructured":"Radonjic NV, Hess JL, Rovira P, Andreassen O, Buitelaar JK, Ching CRK, et al. Structural brain imaging studies offer clues about the effects of the shared genetic etiology among neuropsychiatric disorders. Mol Psychiatry. 2021;26:2101\u201310.","journal-title":"Mol Psychiatry"},{"key":"2115_CR68","doi-asserted-by":"publisher","first-page":"146546","DOI":"10.1016\/j.brainres.2019.146546","volume":"1727","author":"F Chen","year":"2020","unstructured":"Chen F, Bertelsen AB, Holm IE, Nyengaard JR, Rosenberg R, Dorph-Petersen KA. Hippocampal volume and cell number in depression, schizophrenia, and suicide subjects. Brain Res. 2020;1727:146546.","journal-title":"Brain Res"},{"key":"2115_CR69","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1038\/mp.2015.227","volume":"21","author":"DP Hibar","year":"2016","unstructured":"Hibar DP, Westlye LT, van Erp TG, Rasmussen J, Leonardo CD, Faskowitz J, et al. Subcortical volumetric abnormalities in bipolar disorder. Mol Psychiatry. 2016;21:1710\u20136.","journal-title":"Mol Psychiatry"},{"key":"2115_CR70","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1038\/mp.2015.69","volume":"21","author":"L Schmaal","year":"2016","unstructured":"Schmaal L, Veltman DJ, van Erp TG, Samann PG, Frodl T, Jahanshad N, et al. Subcortical brain alterations in major depressive disorder: findings from the ENIGMA Major Depressive Disorder working group. Mol Psychiatry. 2016;21:806\u201312.","journal-title":"Mol Psychiatry"},{"key":"2115_CR71","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.conb.2012.11.004","volume":"23","author":"PJ Uhlhaas","year":"2013","unstructured":"Uhlhaas PJ. Dysconnectivity, large-scale networks and neuronal dynamics in schizophrenia. Curr Opin Neurobiol. 2013;23:283\u201390.","journal-title":"Curr Opin Neurobiol"},{"key":"2115_CR72","doi-asserted-by":"publisher","first-page":"4315","DOI":"10.1016\/j.cell.2021.06.012","volume":"184","author":"MM Nour","year":"2021","unstructured":"Nour MM, Liu Y, Arumuham A, Kurth-Nelson Z, Dolan RJ. Impaired neural replay of inferred relationships in schizophrenia. Cell. 2021;184:4315\u201328.e4317.","journal-title":"Cell"},{"key":"2115_CR73","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/BF00707308","volume":"173","author":"H-G Olbrich","year":"1985","unstructured":"Olbrich H-G, Braak H. Ratio of pyramidal cells versus non-pyramidal cells in sector CA1 of the human Ammon\u2019s horn. Anat Embryol. 1985;173:105\u201310.","journal-title":"Anat Embryol"},{"key":"2115_CR74","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/nrn2044","volume":"8","author":"M Bartos","year":"2007","unstructured":"Bartos M, Vida I, Jonas P. Synaptic mechanisms of synchronized gamma oscillations in inhibitory interneuron networks. Nat Rev Neurosci. 2007;8:45\u201356.","journal-title":"Nat Rev Neurosci"},{"key":"2115_CR75","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.tins.2007.05.005","volume":"30","author":"P Fries","year":"2007","unstructured":"Fries P, Nikolic D, Singer W. The gamma cycle. Trends Neurosci. 2007;30:309\u201316.","journal-title":"Trends Neurosci"},{"key":"2115_CR76","doi-asserted-by":"publisher","DOI":"10.1007\/s11920-012-0346-z","volume":"15","author":"JM McNally","year":"2013","unstructured":"McNally JM, McCarley RW, Brown RE. Impaired GABAergic neurotransmission in schizophrenia underlies impairments in cortical gamma band oscillations. Curr Psychiatry Rep. 2013;15:346.","journal-title":"Curr Psychiatry Rep"},{"key":"2115_CR77","doi-asserted-by":"publisher","first-page":"7668","DOI":"10.1523\/JNEUROSCI.0261-20.2020","volume":"40","author":"P Antonoudiou","year":"2020","unstructured":"Antonoudiou P, Tan YL, Kontou G, Upton AL, Mann EO. Parvalbumin and somatostatin interneurons contribute to the generation of hippocampal gamma oscillations. J Neurosci. 2020;40:7668\u201387.","journal-title":"J Neurosci"},{"key":"2115_CR78","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1523\/JNEUROSCI.5419-08.2009","volume":"29","author":"DJ Lodge","year":"2009","unstructured":"Lodge DJ, Behrens MM, Grace AA. A loss of parvalbumin-containing interneurons is associated with diminished oscillatory activity in an animal model of schizophrenia. J Neurosci. 2009;29:2344\u201354.","journal-title":"J Neurosci"},{"key":"2115_CR79","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/nature07991","volume":"459","author":"VS Sohal","year":"2009","unstructured":"Sohal VS, Zhang F, Yizhar O, Deisseroth K. Parvalbumin neurons and gamma rhythms enhance cortical circuit performance. Nature. 2009;459:698\u2013702.","journal-title":"Nature"},{"key":"2115_CR80","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/mp.2011.31","volume":"17","author":"M Carlen","year":"2012","unstructured":"Carlen M, Meletis K, Siegle JH, Cardin JA, Futai K, Vierling-Claassen D, et al. A critical role for NMDA receptors in parvalbumin interneurons for gamma rhythm induction and behavior. Mol Psychiatry. 2012;17:537\u201348.","journal-title":"Mol Psychiatry"},{"key":"2115_CR81","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1038\/nn.3572","volume":"16","author":"J Song","year":"2013","unstructured":"Song J, Sun J, Moss J, Wen Z, Sun GJ, Hsu D, et al. Parvalbumin interneurons mediate neuronal circuitry-neurogenesis coupling in the adult hippocampus. Nat Neurosci. 2013;16:1728\u201330.","journal-title":"Nat Neurosci"},{"key":"2115_CR82","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1002\/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I","volume":"6","author":"TF Freund","year":"1996","unstructured":"Freund TF, Buzs\u00e1ki G. Interneurons of the hippocampus. Hippocampus. 1996;6:347\u2013470.","journal-title":"Hippocampus"},{"key":"2115_CR83","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1002\/dneu.20853","volume":"71","author":"B Rudy","year":"2011","unstructured":"Rudy B, Fishell G, Lee S, Hjerling-Leffler J. Three groups of interneurons account for nearly 100% of neocortical GABAergic neurons. Dev Neurobiol. 2011;71:45\u201361.","journal-title":"Dev Neurobiol"},{"key":"2115_CR84","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s00401-011-0881-4","volume":"122","author":"AY Wang","year":"2011","unstructured":"Wang AY, Lohmann KM, Yang CK, Zimmerman EI, Pantazopoulos H, Herring N, et al. Bipolar disorder type 1 and schizophrenia are accompanied by decreased density of parvalbumin- and somatostatin-positive interneurons in the parahippocampal region. Acta Neuropathol. 2011;122:615\u201326.","journal-title":"Acta Neuropathol"},{"key":"2115_CR85","first-page":"819","volume":"115","author":"Z Zhang","year":"2002","unstructured":"Zhang Z, Sun J, Reynolds GP. A selective reduction in the relative density of parvalbumin-immunoreactive neurons in the hippocampus in schizophrenia patients. Chin Med J. 2002;115:819\u201323.","journal-title":"Chin Med J"},{"key":"2115_CR86","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-14122-0","volume":"11","author":"EC Onwordi","year":"2020","unstructured":"Onwordi EC, Halff EF, Whitehurst T, Mansur A, Cotel MC, Wells L, et al. Synaptic density marker SV2A is reduced in schizophrenia patients and unaffected by antipsychotics in rats. Nat Commun. 2020;11:246.","journal-title":"Nat Commun"},{"key":"2115_CR87","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-021-01515-3","volume":"11","author":"EC Onwordi","year":"2021","unstructured":"Onwordi EC, Whitehurst T, Mansur A, Statton B, Berry A, Quinlan M, et al. The relationship between synaptic density marker SV2A, glutamate and N-acetyl aspartate levels in healthy volunteers and schizophrenia: a multimodal PET and magnetic resonance spectroscopy brain imaging study. Transl Psychiatry. 2021;11:393.","journal-title":"Transl Psychiatry"},{"key":"2115_CR88","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/s41380-018-0041-5","volume":"24","author":"EF Osimo","year":"2019","unstructured":"Osimo EF, Beck K, Reis Marques T, Howes OD. Synaptic loss in schizophrenia: a meta-analysis and systematic review of synaptic protein and mRNA measures. Mol Psychiatry. 2019;24:549\u201361.","journal-title":"Mol Psychiatry"},{"key":"2115_CR89","doi-asserted-by":"publisher","first-page":"7690","DOI":"10.1038\/s41380-021-01184-0","volume":"26","author":"R Radhakrishnan","year":"2021","unstructured":"Radhakrishnan R, Skosnik PD, Ranganathan M, Naganawa M, Toyonaga T, Finnema S, et al. In vivo evidence of lower synaptic vesicle density in schizophrenia. Mol Psychiatry. 2021;26:7690\u20138.","journal-title":"Mol Psychiatry"},{"key":"2115_CR90","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1016\/j.neuron.2013.07.010","volume":"79","author":"I Del Pino","year":"2013","unstructured":"Del Pino I, Garcia-Frigola C, Dehorter N, Brotons-Mas JR, Alvarez-Salvado E, Martinez de Lagran M, et al. Erbb4 deletion from fast-spiking interneurons causes schizophrenia-like phenotypes. Neuron. 2013;79:1152\u201368.","journal-title":"Neuron"},{"key":"2115_CR91","doi-asserted-by":"publisher","unstructured":"Kiemes A, Serrano Navacerrada ME, Kim E, Randall K, Simmons C, Rojo Gonzalez L, et al. Erbb4 deletion from fast-spiking interneurons causes psychosis-relevant neuroimaging phenotypes. bioRxiv. 2022; https:\/\/doi.org\/10.1101\/2022.03.07.483347.","DOI":"10.1101\/2022.03.07.483347"},{"key":"2115_CR92","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.tins.2008.02.005","volume":"31","author":"JE Lisman","year":"2008","unstructured":"Lisman JE, Coyle JT, Green RW, Javitt DC, Benes FM, Heckers S, et al. Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia. Trends Neurosci. 2008;31:234\u201342.","journal-title":"Trends Neurosci"},{"key":"2115_CR93","doi-asserted-by":"publisher","first-page":"107426","DOI":"10.1016\/j.pharmthera.2019.107426","volume":"205","author":"K Nakazawa","year":"2020","unstructured":"Nakazawa K, Sapkota K. The origin of NMDA receptor hypofunction in schizophrenia. Pharm Ther. 2020;205:107426.","journal-title":"Pharm Ther"},{"key":"2115_CR94","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1177\/0269881107067097","volume":"21","author":"Z Abdul-Monim","year":"2007","unstructured":"Abdul-Monim Z, Neill JC, Reynolds GP. Sub-chronic psychotomimetic phencyclidine induces deficits in reversal learning and alterations in parvalbumin-immunoreactive expression in the rat. J Psychopharmacol. 2007;21:198\u2013205.","journal-title":"J Psychopharmacol"},{"key":"2115_CR95","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1002\/dneu.20844","volume":"71","author":"Z Zhang","year":"2011","unstructured":"Zhang Z, Sun QQ. Development of NMDA NR2 subunits and their roles in critical period maturation of neocortical GABAergic interneurons. Dev Neurobiol. 2011;71:221\u201345.","journal-title":"Dev Neurobiol"},{"key":"2115_CR96","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.neuroscience.2018.09.031","volume":"393","author":"JA Honeycutt","year":"2018","unstructured":"Honeycutt JA, Chrobak JJ. Parvalbumin loss following chronic sub-anesthetic NMDA antagonist treatment is age-dependent in the hippocampus: implications for modeling NMDA hypofunction. Neuroscience. 2018;393:73\u201382.","journal-title":"Neuroscience"},{"key":"2115_CR97","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/sj.mp.4001751","volume":"11","author":"LS Pilowsky","year":"2006","unstructured":"Pilowsky LS, Bressan RA, Stone JM, Erlandsson K, Mulligan RS, Krystal JH, et al. First in vivo evidence of an NMDA receptor deficit in medication-free schizophrenic patients. Mol Psychiatry. 2006;11:118\u20139.","journal-title":"Mol Psychiatry"},{"key":"2115_CR98","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-021-01540-2","volume":"11","author":"K Beck","year":"2021","unstructured":"Beck K, Arumuham A, Veronese M, Santangelo B, McGinnity CJ, Dunn J, et al. N-methyl-D-aspartate receptor availability in first-episode psychosis: a PET-MR brain imaging study. Transl Psychiatry. 2021;11:425.","journal-title":"Transl Psychiatry"},{"key":"2115_CR99","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1177\/0271678X211045449","volume":"42","author":"Y Takado","year":"2022","unstructured":"Takado Y, Takuwa H, Sampei K, Urushihata T, Takahashi M, Shimojo M, et al. MRS-measured glutamate versus GABA reflects excitatory versus inhibitory neural activities in awake mice. J Cereb Blood Flow Metab. 2022;42:197\u2013212.","journal-title":"J Cereb Blood Flow Metab"},{"key":"2115_CR100","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1038\/s41380-021-01297-6","volume":"27","author":"T Nakahara","year":"2022","unstructured":"Nakahara T, Tsugawa S, Noda Y, Ueno F, Honda S, Kinjo M, et al. Glutamatergic and GABAergic metabolite levels in schizophrenia-spectrum disorders: a meta-analysis of (1)H-magnetic resonance spectroscopy studies. Mol Psychiatry. 2022;27:744\u201357.","journal-title":"Mol Psychiatry"},{"key":"2115_CR101","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1001\/jamapsychiatry.2018.3252","volume":"76","author":"MG Bossong","year":"2019","unstructured":"Bossong MG, Antoniades M, Azis M, Samson C, Quinn B, Bonoldi I, et al. Association of hippocampal glutamate levels with adverse outcomes in individuals at clinical high risk for psychosis. JAMA Psychiatry. 2019;76:199\u2013207.","journal-title":"JAMA Psychiatry"},{"key":"2115_CR102","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.biopsych.2019.09.022","volume":"87","author":"FA Provenzano","year":"2020","unstructured":"Provenzano FA, Guo J, Wall MM, Feng X, Sigmon HC, Brucato G, et al. Hippocampal pathology in clinical high-risk patients and the onset of schizophrenia. Biol Psychiatry. 2020;87:234\u201342.","journal-title":"Biol Psychiatry"},{"key":"2115_CR103","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.biopsych.2010.05.034","volume":"68","author":"JM Stone","year":"2010","unstructured":"Stone JM, Howes OD, Egerton A, Kambeitz J, Allen P, Lythgoe DJ, et al. Altered relationship between hippocampal glutamate levels and striatal dopamine function in subjects at ultra high risk of psychosis. Biol Psychiatry. 2010;68:599\u2013602.","journal-title":"Biol Psychiatry"},{"key":"2115_CR104","doi-asserted-by":"publisher","first-page":"11424","DOI":"10.1523\/JNEUROSCI.2847-07.2007","volume":"27","author":"DJ Lodge","year":"2007","unstructured":"Lodge DJ, Grace AA. Aberrant hippocampal activity underlies the dopamine dysregulation in an animal model of schizophrenia. J Neurosci. 2007;27:11424\u201330.","journal-title":"J Neurosci"},{"key":"2115_CR105","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1002\/nbm.1055","volume":"19","author":"TN Venkatraman","year":"2006","unstructured":"Venkatraman TN, Hamer RM, Perkins DO, Song AW, Lieberman JA, Steen RG. Single-voxel 1H PRESS at 4.0 T: precision and variability of measurements in anterior cingulate and hippocampus. NMR Biomed. 2006;19:484\u201391.","journal-title":"NMR Biomed"},{"key":"2115_CR106","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/mp.2014.54","volume":"20","author":"AD Stan","year":"2015","unstructured":"Stan AD, Ghose S, Zhao C, Hulsey K, Mihalakos P, Yanagi M, et al. Magnetic resonance spectroscopy and tissue protein concentrations together suggest lower glutamate signaling in dentate gyrus in schizophrenia. Mol Psychiatry. 2015;20:433\u20139.","journal-title":"Mol Psychiatry"},{"key":"2115_CR107","doi-asserted-by":"publisher","first-page":"656459","DOI":"10.3389\/fpsyt.2021.656459","volume":"12","author":"SA Wijtenburg","year":"2021","unstructured":"Wijtenburg SA, Wang M, Korenic SA, Chen S, Barker PB, Rowland LM. Metabolite alterations in adults with schizophrenia, first degree relatives, and healthy controls: a multi-region 7T MRS study. Front Psychiatry. 2021;12:656459.","journal-title":"Front Psychiatry"},{"key":"2115_CR108","doi-asserted-by":"publisher","first-page":"2652","DOI":"10.1038\/s41386-017-0004-6","volume":"43","author":"G Modinos","year":"2018","unstructured":"Modinos G, Simsek F, Azis M, Bossong M, Bonoldi I, Samson C, et al. Prefrontal GABA levels, hippocampal resting perfusion and the risk of psychosis. Neuropsychopharmacology. 2018;43:2652\u20139.","journal-title":"Neuropsychopharmacology"},{"key":"2115_CR109","doi-asserted-by":"publisher","first-page":"2616","DOI":"10.1038\/s41380-020-0711-y","volume":"26","author":"TR Marques","year":"2021","unstructured":"Marques TR, Ashok AH, Angelescu I, Borgan F, Myers J, Lingford-Hughes A, et al. GABA-A receptor differences in schizophrenia: a positron emission tomography study using [(11)C]Ro154513. Mol Psychiatry. 2021;26:2616\u201325.","journal-title":"Mol Psychiatry"},{"key":"2115_CR110","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.euroneuro.2020.10.004","volume":"41","author":"A Peris-Yague","year":"2020","unstructured":"Peris-Yague A, Kiemes A, Cash D, Cotel MC, Singh N, Vernon AC, et al. Region-specific and dose-specific effects of chronic haloperidol exposure on [(3)H]-flumazenil and [(3)H]-Ro15-4513 GABAA receptor binding sites in the rat brain. Eur Neuropsychopharmacol. 2020;41:106\u201317.","journal-title":"Eur Neuropsychopharmacol"},{"key":"2115_CR111","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1093\/schbul\/sbaa086","volume":"46","author":"A Marsman","year":"2020","unstructured":"Marsman A, Pries L-K, ten Have M, de Graaf R, van Dorsselaer S, Bak M, et al. Do Current Measures of Polygenic Risk for Mental Disorders Contribute to Population Variance in Mental Health? Schizophrenia Bull. 2020;46:1353\u201362.","journal-title":"Schizophrenia Bull"},{"key":"2115_CR112","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.bbi.2014.04.005","volume":"40","author":"S Giovanoli","year":"2014","unstructured":"Giovanoli S, Weber L, Meyer U. Single and combined effects of prenatal immune activation and peripubertal stress on parvalbumin and reelin expression in the hippocampal formation. Brain Behav Immun. 2014;40:48\u201354.","journal-title":"Brain Behav Immun"},{"key":"2115_CR113","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/j.biopsych.2019.02.021","volume":"85","author":"S Murthy","year":"2019","unstructured":"Murthy S, Kane GA, Katchur NJ, Lara Mejia PS, Obiofuma G, Buschman TJ, et al. Perineuronal nets, inhibitory interneurons, and anxiety-related ventral hippocampal neuronal oscillations are altered by early life adversity. Biol Psychiatry. 2019;85:1011\u201320.","journal-title":"Biol Psychiatry"},{"key":"2115_CR114","doi-asserted-by":"publisher","first-page":"3278","DOI":"10.1038\/s41380-019-0514-1","volume":"25","author":"FV Gomes","year":"2020","unstructured":"Gomes FV, Zhu X, Grace AA. The pathophysiological impact of stress on the dopamine system is dependent on the state of the critical period of vulnerability. Mol Psychiatry. 2020;25:3278\u201391.","journal-title":"Mol Psychiatry"},{"key":"2115_CR115","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17854-6","volume":"11","author":"AL Decker","year":"2020","unstructured":"Decker AL, Duncan K, Finn AS, Mabbott DJ. Children\u2019s family income is associated with cognitive function and volume of anterior not posterior hippocampus. Nat Commun. 2020;11:4040.","journal-title":"Nat Commun"},{"key":"2115_CR116","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1176\/appi.ajp.158.8.1248","volume":"158","author":"O Bonne","year":"2001","unstructured":"Bonne O, Brandes D, Gilboa A, Gomori JM, Shenton ME, Pitman RK, et al. Longitudinal MRI study of hippocampal volume in trauma survivors with PTSD. Am J Psychiatry. 2001;158:1248\u201351.","journal-title":"Am J Psychiatry"},{"key":"2115_CR117","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.pneurobio.2010.09.003","volume":"93","author":"AS Brown","year":"2011","unstructured":"Brown AS. The environment and susceptibility to schizophrenia. Prog Neurobiol. 2011;93:23\u201358.","journal-title":"Prog Neurobiol"},{"key":"2115_CR118","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1016\/j.jpsychires.2013.05.008","volume":"47","author":"E Samplin","year":"2013","unstructured":"Samplin E, Ikuta T, Malhotra AK, Szeszko PR, DeRosse P. Sex differences in resilience to childhood maltreatment: effects of trauma history on hippocampal volume, general cognition and subclinical psychosis in healthy adults. J Psychiatr Res. 2013;47:1174\u20139.","journal-title":"J Psychiatr Res"},{"key":"2115_CR119","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.neuroimage.2017.12.055","volume":"169","author":"MH Teicher","year":"2018","unstructured":"Teicher MH, Anderson CM, Ohashi K, Khan A, McGreenery CE, Bolger EA, et al. Differential effects of childhood neglect and abuse during sensitive exposure periods on male and female hippocampus. Neuroimage. 2018;169:443\u201352.","journal-title":"Neuroimage"},{"key":"2115_CR120","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1017\/S003329171200089X","volume":"43","author":"SV Eranti","year":"2013","unstructured":"Eranti SV, MacCabe JH, Bundy H, Murray RM. Gender difference in age at onset of schizophrenia: a meta-analysis. Psychological Med. 2013;43:155\u201367.","journal-title":"Psychological Med"},{"key":"2115_CR121","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nrn849","volume":"3","author":"JJ Kim","year":"2002","unstructured":"Kim JJ, Diamond DM. The stressed hippocampus, synaptic plasticity and lost memories. Nat Rev Neurosci. 2002;3:453\u201362.","journal-title":"Nat Rev Neurosci"},{"key":"2115_CR122","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1080\/j.1440-1614.2006.01877.x","volume":"40","author":"LJ Phillips","year":"2006","unstructured":"Phillips LJ, McGorry PD, Garner B, Thompson KN, Pantelis C, Wood SJ, et al. Stress, the hippocampus and the hypothalamic-pituitary-adrenal axis: implications for the development of psychotic disorders. Aust N. Z J Psychiatry. 2006;40:725\u201341.","journal-title":"Aust N. Z J Psychiatry"},{"key":"2115_CR123","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.tics.2006.02.002","volume":"10","author":"M Jo\u00ebls","year":"2006","unstructured":"Jo\u00ebls M, Pu Z, Wiegert O, Oitzl MS, Krugers HJ. Learning under stress: how does it work? Trends Cogn Sci. 2006;10:152\u20138.","journal-title":"Trends Cogn Sci"},{"key":"2115_CR124","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1146\/annurev.neuro.22.1.105","volume":"22","author":"BS McEwen","year":"1999","unstructured":"McEwen BS. Stress and hippocampal plasticity. Annu Rev Neurosci. 1999;22:105\u201322.","journal-title":"Annu Rev Neurosci"},{"key":"2115_CR125","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1038\/nrn1555","volume":"5","author":"C Sandi","year":"2004","unstructured":"Sandi C. Stress, cognitive impairment and cell adhesion molecules. Nat Rev Neurosci. 2004;5:917\u201330.","journal-title":"Nat Rev Neurosci"},{"key":"2115_CR126","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/0006-8993(90)90778-A","volume":"531","author":"CS Woolley","year":"1990","unstructured":"Woolley CS, Gould E, McEwen BS. Exposure to excess glucocorticoids alters dendritic morphology of adult hippocampal pyramidal neurons. Brain Res. 1990;531:225\u201331.","journal-title":"Brain Res"},{"key":"2115_CR127","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/nrn.2017.45","volume":"18","author":"C Anacker","year":"2017","unstructured":"Anacker C, Hen R. Adult hippocampal neurogenesis and cognitive flexibility\u2014linking memory and mood. Nat Rev Neurosci. 2017;18:335\u201346.","journal-title":"Nat Rev Neurosci"},{"key":"2115_CR128","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1146\/annurev.clinpsy.4.022007.141248","volume":"4","author":"E Walker","year":"2008","unstructured":"Walker E, Mittal V, Tessner K. Stress and the hypothalamic pituitary adrenal axis in the developmental course of schizophrenia. Annu Rev Clin Psychol. 2008;4:189\u2013216.","journal-title":"Annu Rev Clin Psychol"},{"key":"2115_CR129","first-page":"456","volume":"8","author":"JG Spiers","year":"2014","unstructured":"Spiers JG, Chen HJ, Sernia C, Lavidis NA. Activation of the hypothalamic-pituitary-adrenal stress axis induces cellular oxidative stress. Front Neurosci. 2014;8:456.","journal-title":"Front Neurosci"},{"key":"2115_CR130","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.biopsych.2020.03.016","volume":"88","author":"DO Perkins","year":"2020","unstructured":"Perkins DO, Jeffries CD, Do KQ. Potential roles of redox dysregulation in the development of schizophrenia. Biol Psychiatry. 2020;88:326\u201336.","journal-title":"Biol Psychiatry"},{"key":"2115_CR131","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.biocel.2006.07.001","volume":"39","author":"M Valko","year":"2007","unstructured":"Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol. 2007;39:44\u201384.","journal-title":"Int J Biochem Cell Biol"},{"key":"2115_CR132","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1038\/jcbfm.2014.104","volume":"34","author":"O Kann","year":"2014","unstructured":"Kann O, Papageorgiou IE, Draguhn A. Highly energized inhibitory interneurons are a central element for information processing in cortical networks. J Cereb Blood Flow Metab. 2014;34:1270\u201382.","journal-title":"J Cereb Blood Flow Metab"},{"key":"2115_CR133","doi-asserted-by":"publisher","first-page":"9130","DOI":"10.1073\/pnas.1300454110","volume":"110","author":"JH Cabungcal","year":"2013","unstructured":"Cabungcal JH, Steullet P, Morishita H, Kraftsik R, Cuenod M, Hensch TK, et al. Perineuronal nets protect fast-spiking interneurons against oxidative stress. Proc Natl Acad Sci USA. 2013;110:9130\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2115_CR134","doi-asserted-by":"publisher","first-page":"2547","DOI":"10.1523\/JNEUROSCI.3857-09.2010","volume":"30","author":"P Steullet","year":"2010","unstructured":"Steullet P, Cabungcal JH, Kulak A, Kraftsik R, Chen Y, Dalton TP, et al. Redox dysregulation affects the ventral but not dorsal hippocampus: impairment of parvalbumin neurons, gamma oscillations, and related behaviors. J Neurosci. 2010;30:2547\u201358.","journal-title":"J Neurosci"},{"key":"2115_CR135","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.biopsych.2012.09.020","volume":"73","author":"JH Cabungcal","year":"2013","unstructured":"Cabungcal JH, Steullet P, Kraftsik R, Cuenod M, Do KQ. Early-life insults impair parvalbumin interneurons via oxidative stress: reversal by N-acetylcysteine. Biol Psychiatry. 2013;73:574\u201382.","journal-title":"Biol Psychiatry"},{"key":"2115_CR136","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.conb.2009.05.001","volume":"19","author":"KQ Do","year":"2009","unstructured":"Do KQ, Cabungcal JH, Frank A, Steullet P, Cuenod M. Redox dysregulation, neurodevelopment, and schizophrenia. Curr Opin Neurobiol. 2009;19:220\u201330.","journal-title":"Curr Opin Neurobiol"},{"key":"2115_CR137","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.biopsych.2013.03.018","volume":"74","author":"J Flatow","year":"2013","unstructured":"Flatow J, Buckley P, Miller BJ. Meta-analysis of oxidative stress in schizophrenia. Biol Psychiatry. 2013;74:400\u20139.","journal-title":"Biol Psychiatry"},{"key":"2115_CR138","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.schres.2015.06.022","volume":"176","author":"M Koga","year":"2016","unstructured":"Koga M, Serritella AV, Sawa A, Sedlak TW. Implications for reactive oxygen species in schizophrenia pathogenesis. Schizophr Res. 2016;176:52\u201371.","journal-title":"Schizophr Res"},{"key":"2115_CR139","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1097\/00019442-200403000-00008","volume":"12","author":"N Nishioka","year":"2004","unstructured":"Nishioka N, Arnold SE. Evidence for oxidative DNA damage in the hippocampus of elderly patients with chronic schizophrenia. Am J Geriatr Psychiatry. 2004;12:167\u201375.","journal-title":"Am J Geriatr Psychiatry"},{"key":"2115_CR140","doi-asserted-by":"publisher","first-page":"pyv110","DOI":"10.1093\/ijnp\/pyv110","volume":"19","author":"A Corcoba","year":"2015","unstructured":"Corcoba A, Steullet P, Duarte JM, Van de Looij Y, Monin A, Cuenod M, et al. Glutathione deficit affects the integrity and function of the fimbria\/fornix and anterior commissure in mice: relevance for schizophrenia. Int J Neuropsychopharmacol. 2015;19:pyv110.","journal-title":"Int J Neuropsychopharmacol"},{"key":"2115_CR141","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.schres.2014.04.022","volume":"156","author":"J Fitzsimmons","year":"2014","unstructured":"Fitzsimmons J, Hamoda HM, Swisher T, Terry D, Rosenberger G, Seidman LJ, et al. Diffusion tensor imaging study of the fornix in first episode schizophrenia and in healthy controls. Schizophr Res. 2014;156:157\u201360.","journal-title":"Schizophr Res"},{"key":"2115_CR142","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.pnpbp.2018.08.006","volume":"91","author":"TK Das","year":"2019","unstructured":"Das TK, Javadzadeh A, Dey A, Sabesan P, Theberge J, Radua J, et al. Antioxidant defense in schizophrenia and bipolar disorder: a meta-analysis of MRS studies of anterior cingulate glutathione. Prog Neuropsychopharmacol Biol Psychiatry. 2019;91:94\u2013102.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"2115_CR143","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1177\/0269881119845820","volume":"33","author":"S Tsugawa","year":"2019","unstructured":"Tsugawa S, Noda Y, Tarumi R, Mimura Y, Yoshida K, Iwata Y, et al. Glutathione levels and activities of glutathione metabolism enzymes in patients with schizophrenia: a systematic review and meta-analysis. J Psychopharmacol. 2019;33:1199\u2013214.","journal-title":"J Psychopharmacol"},{"key":"2115_CR144","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.nbd.2008.11.018","volume":"33","author":"SJ Wood","year":"2009","unstructured":"Wood SJ, Berger GE, Wellard RM, Proffitt TM, McConchie M, Berk M, et al. Medial temporal lobe glutathione concentration in first episode psychosis: a 1H-MRS investigation. Neurobiol Dis. 2009;33:354\u20137.","journal-title":"Neurobiol Dis"},{"key":"2115_CR145","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1093\/schbul\/sbw038","volume":"42","author":"L Xin","year":"2016","unstructured":"Xin L, Mekle R, Fournier M, Baumann PS, Ferrari C, Alameda L, et al. Genetic polymorphism associated prefrontal glutathione and its coupling with brain glutamate and peripheral redox status in early psychosis. Schizophr Bull. 2016;42:1185\u201396.","journal-title":"Schizophr Bull"},{"key":"2115_CR146","doi-asserted-by":"publisher","first-page":"16621","DOI":"10.1073\/pnas.0706778104","volume":"104","author":"R Gysin","year":"2007","unstructured":"Gysin R, Kraftsik R, Sandell J, Bovet P, Chappuis C, Conus P, et al. Impaired glutathione synthesis in schizophrenia: convergent genetic and functional evidence. Proc Natl Acad Sci USA. 2007;104:16621\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2115_CR147","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2016.117","volume":"6","author":"PS Baumann","year":"2016","unstructured":"Baumann PS, Griffa A, Fournier M, Golay P, Ferrari C, Alameda L, et al. Impaired fornix-hippocampus integrity is linked to peripheral glutathione peroxidase in early psychosis. Transl Psychiatry. 2016;6:e859.","journal-title":"Transl Psychiatry"},{"key":"2115_CR148","doi-asserted-by":"publisher","first-page":"12495","DOI":"10.1073\/pnas.1812821115","volume":"115","author":"L Alameda","year":"2018","unstructured":"Alameda L, Fournier M, Khadimallah I, Griffa A, Cleusix M, Jenni R, et al. Redox dysregulation as a link between childhood trauma and psychopathological and neurocognitive profile in patients with early psychosis. Proc Natl Acad Sci USA. 2018;115:12495\u2013500.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2115_CR149","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1093\/schbul\/sbv065","volume":"41","author":"KQ Do","year":"2015","unstructured":"Do KQ, Cuenod M, Hensch TK. Targeting oxidative stress and aberrant critical period plasticity in the developmental trajectory to schizophrenia. Schizophr Bull. 2015;41:835\u201346.","journal-title":"Schizophr Bull"},{"key":"2115_CR150","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.neuroscience.2018.05.039","volume":"384","author":"SL Rogers","year":"2018","unstructured":"Rogers SL, Rankin-Gee E, Risbud RM, Porter BE, Marsh ED. Normal development of the perineuronal net in humans; in patients with and without epilepsy. Neuroscience. 2018;384:350\u201360.","journal-title":"Neuroscience"},{"key":"2115_CR151","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.schres.2014.12.040","volume":"167","author":"S Berretta","year":"2015","unstructured":"Berretta S, Pantazopoulos H, Markota M, Brown C, Batzianouli ET. Losing the sugar coating: potential impact of perineuronal net abnormalities on interneurons in schizophrenia. Schizophr Res. 2015;167:18\u201327.","journal-title":"Schizophr Res"},{"key":"2115_CR152","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.biopsych.2013.05.007","volume":"74","author":"SA Mauney","year":"2013","unstructured":"Mauney SA, Athanas KM, Pantazopoulos H, Shaskan N, Passeri E, Berretta S, et al. Developmental pattern of perineuronal nets in the human prefrontal cortex and their deficit in schizophrenia. Biol Psychiatry. 2013;74:427\u201335.","journal-title":"Biol Psychiatry"},{"key":"2115_CR153","first-page":"S298","volume":"39","author":"H Pantazopoulos","year":"2014","unstructured":"Pantazopoulos H, Sawyer C, Heckers S, Berretta S, Markota M. Chondroitin sulfate proteoglycan abnormalities in the hippocampus of subjects with schizophrenia. Neuropsychopharmacology. 2014;39:S298\u2013S299.","journal-title":"Neuropsychopharmacology"},{"key":"2115_CR154","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1016\/j.psychres.2018.10.062","volume":"270","author":"T Yukawa","year":"2018","unstructured":"Yukawa T, Iwakura Y, Takei N, Saito M, Watanabe Y, Toyooka K, et al. Pathological alterations of chondroitin sulfate moiety in postmortem hippocampus of patients with schizophrenia. Psychiatry Res. 2018;270:940\u20136.","journal-title":"Psychiatry Res"},{"key":"2115_CR155","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2012.145","volume":"3","author":"A Shah","year":"2013","unstructured":"Shah A, Lodge DJ. A loss of hippocampal perineuronal nets produces deficits in dopamine system function: relevance to the positive symptoms of schizophrenia. Transl Psychiatry. 2013;3:e215.","journal-title":"Transl Psychiatry"},{"key":"2115_CR156","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1093\/schbul\/sbab047","volume":"47","author":"SF Sonnenschein","year":"2021","unstructured":"Sonnenschein SF, Grace AA. Peripubertal mGluR2\/3 agonist treatment prevents hippocampal dysfunction and dopamine system hyperactivity in adulthood in MAM model of schizophrenia. Schizophr Bull. 2021;47:1806\u201314.","journal-title":"Schizophr Bull"},{"key":"2115_CR157","first-page":"758212","volume":"2014","author":"DH Adams","year":"2014","unstructured":"Adams DH, Zhang L, Millen BA, Kinon BJ, Gomez JC. Pomaglumetad methionil (LY2140023 monohydrate) and aripiprazole in patients with schizophrenia: a phase 3, multicenter, double-blind comparison. Schizophr Res Treat. 2014;2014:758212.","journal-title":"Schizophr Res Treat"},{"key":"2115_CR158","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.schres.2013.08.020","volume":"150","author":"VL Stauffer","year":"2013","unstructured":"Stauffer VL, Millen BA, Andersen S, Kinon BJ, LaGrandeur L, Lindenmayer JP, et al. Pomaglumetad methionil: No significant difference as an adjunctive treatment for patients with prominent negative symptoms of schizophrenia compared to placebo. Schizophrenia Res. 2013;150:434\u201341.","journal-title":"Schizophrenia Res"},{"key":"2115_CR159","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.biopsych.2016.11.014","volume":"82","author":"D Bugarski-Kirola","year":"2017","unstructured":"Bugarski-Kirola D, Blaettler T, Arango C, Fleischhacker WW, Garibaldi G, Wang A, et al. Bitopertin in Negative Symptoms of Schizophrenia\u2014Results from the phase III FlashLyte and DayLyte studies. Biol Psychiatry. 2017;82:8\u201316.","journal-title":"Biol Psychiatry"},{"key":"2115_CR160","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1038\/mp.2013.111","volume":"18","author":"SM Perez","year":"2013","unstructured":"Perez SM, Lodge DJ. Hippocampal interneuron transplants reverse aberrant dopamine system function and behavior in a rodent model of schizophrenia. Mol Psychiatry. 2013;18:1193\u20138.","journal-title":"Mol Psychiatry"},{"key":"2115_CR161","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1038\/npp.2013.101","volume":"38","author":"Y Du","year":"2013","unstructured":"Du Y, Grace AA. Peripubertal diazepam administration prevents the emergence of dopamine system hyperresponsivity in the MAM developmental disruption model of schizophrenia. Neuropsychopharmacology. 2013;38:1881\u20138.","journal-title":"Neuropsychopharmacology"},{"key":"2115_CR162","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1146\/annurev-pharmtox-011613-135947","volume":"54","author":"U Rudolph","year":"2014","unstructured":"Rudolph U, Mohler H. GABAA receptor subtypes: therapeutic potential in Down syndrome, affective disorders, schizophrenia, and autism. Annu Rev Pharm Toxicol. 2014;54:483\u2013507.","journal-title":"Annu Rev Pharm Toxicol"},{"key":"2115_CR163","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/j.euroneuro.2013.03.001","volume":"23","author":"M Dold","year":"2013","unstructured":"Dold M, Li C, Gillies D, Leucht S. Benzodiazepine augmentation of antipsychotic drugs in schizophrenia: a meta-analysis and Cochrane review of randomized controlled trials. Eur Neuropsychopharmacol. 2013;23:1023\u201333.","journal-title":"Eur Neuropsychopharmacol"},{"key":"2115_CR164","doi-asserted-by":"publisher","first-page":"9861","DOI":"10.1073\/pnas.0308208101","volume":"101","author":"BA Lynch","year":"2004","unstructured":"Lynch BA, Lambeng N, Nocka K, Kensel-Hammes P, Bajjalieh SM, Matagne A, et al. The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam. Proc Natl Acad Sci USA. 2004;101:9861\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2115_CR165","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1124\/jpet.113.208751","volume":"348","author":"M Wakita","year":"2014","unstructured":"Wakita M, Kotani N, Kogure K, Akaike N. Inhibition of excitatory synaptic transmission in hippocampal neurons by levetiracetam involves Zn2+-dependent GABA type a receptor-mediated presynaptic modulation. J Pharmacol Exp Therapeutics. 2014;348:246\u201359.","journal-title":"J Pharmacol Exp Therapeutics"},{"key":"2115_CR166","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.brainres.2019.03.021","volume":"1715","author":"A Vanoye-Carlo","year":"2019","unstructured":"Vanoye-Carlo A, Gomez-Lira G. Differential expression of SV2A in hippocampal glutamatergic and GABAergic terminals during postnatal development. Brain Res. 2019;1715:73\u201383.","journal-title":"Brain Res"},{"key":"2115_CR167","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1093\/schbul\/sbt236","volume":"40","author":"KM Gill","year":"2014","unstructured":"Gill KM, Cook JM, Poe MM, Grace AA. Prior antipsychotic drug treatment prevents response to novel antipsychotic agent in the methylazoxymethanol acetate model of schizophrenia. Schizophrenia Bull. 2014;40:341\u201350.","journal-title":"Schizophrenia Bull"},{"key":"2115_CR168","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.yebeh.2017.08.039","volume":"76","author":"B Chen","year":"2017","unstructured":"Chen B, Choi H, Hirsch LJ, Katz A, Legge A, Buchsbaum R, et al. Psychiatric and behavioral side effects of antiepileptic drugs in adults with epilepsy. Epilepsy Behav. 2017;76:24\u201331.","journal-title":"Epilepsy Behav"},{"key":"2115_CR169","doi-asserted-by":"crossref","unstructured":"Pinckaers FME, Boon ME, Majoie MHJM. Risk factors predisposing to psychotic symptoms during levetiracetam therapy: a retrospective study. Epilepsy Behav. 2019;100.","DOI":"10.1016\/j.yebeh.2019.05.039"},{"key":"2115_CR170","doi-asserted-by":"publisher","first-page":"179","DOI":"10.3389\/fnmol.2019.00179","volume":"12","author":"TC Jacob","year":"2019","unstructured":"Jacob TC. Neurobiology and therapeutic potential of alpha5-GABA type A receptors. Front Mol Neurosci. 2019;12:179.","journal-title":"Front Mol Neurosci"},{"key":"2115_CR171","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1034\/j.1399-5618.2003.00031.x","volume":"5","author":"CL Bowden","year":"2003","unstructured":"Bowden CL. Valproate. Bipolar Disord. 2003;5:189\u2013202.","journal-title":"Bipolar Disord"},{"key":"2115_CR172","doi-asserted-by":"publisher","first-page":"e2475","DOI":"10.1097\/MD.0000000000002475","volume":"95","author":"PT Tseng","year":"2016","unstructured":"Tseng PT, Chen YW, Chung W, Tu KY, Wang HY, Wu CK, et al. Significant effect of valproate augmentation therapy in patients with schizophrenia: a meta-analysis study. Medicine. 2016;95:e2475.","journal-title":"Medicine"},{"key":"2115_CR173","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1007\/s00018-007-7079-x","volume":"64","author":"G Rosenberg","year":"2007","unstructured":"Rosenberg G. The mechanisms of action of valproate in neuropsychiatric disorders: can we see the forest for the trees? Cell Mol Life Sci. 2007;64:2090\u2013103.","journal-title":"Cell Mol Life Sci"},{"key":"2115_CR174","doi-asserted-by":"publisher","first-page":"102","DOI":"10.3389\/fnsys.2013.00102","volume":"7","author":"J Gervain","year":"2013","unstructured":"Gervain J, Vines BW, Chen LM, Seo RJ, Hensch TK, Werker JF, et al. Valproate reopens critical-period learning of absolute pitch. Front Syst Neurosci. 2013;7:102.","journal-title":"Front Syst Neurosci"},{"key":"2115_CR175","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-018-0266-8","volume":"8","author":"P Klauser","year":"2018","unstructured":"Klauser P, Xin L, Fournier M, Griffa A, Cleusix M, Jenni R, et al. N-acetylcysteine add-on treatment leads to an improvement of fornix white matter integrity in early psychosis: a double-blind randomized placebo-controlled trial. Transl Psychiatry. 2018;8:220.","journal-title":"Transl Psychiatry"},{"key":"2115_CR176","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1093\/schbul\/sbx093","volume":"44","author":"P Conus","year":"2018","unstructured":"Conus P, Seidman LJ, Fournier M, Xin L, Cleusix M, Baumann PS, et al. N-acetylcysteine in a double-blind randomized placebo-controlled trial: toward biomarker-guided treatment in early psychosis. Schizophr Bull. 2018;44:317\u201327.","journal-title":"Schizophr Bull"},{"key":"2115_CR177","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.neuron.2014.07.028","volume":"83","author":"JH Cabungcal","year":"2014","unstructured":"Cabungcal JH, Counotte DS, Lewis E, Tejeda HA, Piantadosi P, Pollock C, et al. Juvenile antioxidant treatment prevents adult deficits in a developmental model of schizophrenia. Neuron. 2014;83:1073\u201384.","journal-title":"Neuron"},{"key":"2115_CR178","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1093\/schbul\/sbab066","volume":"47","author":"D Dwir","year":"2021","unstructured":"Dwir D, Cabungcal JH, Xin L, Giangreco B, Parietti E, Cleusix M, et al. Timely N-acetyl-cysteine and environmental enrichment rescue oxidative stress-induced parvalbumin interneuron impairments via MMP9\/RAGE pathway: a translational approach for early intervention in psychosis. Schizophr Bull. 2021;47:1782\u201394.","journal-title":"Schizophr Bull"},{"key":"2115_CR179","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1038\/s41380-021-01374-w","volume":"27","author":"M Cuenod","year":"2022","unstructured":"Cuenod M, Steullet P, Cabungcal JH, Dwir D, Khadimallah I, Klauser P, et al. Caught in vicious circles: a perspective on dynamic feed-forward loops driving oxidative stress in schizophrenia. Mol Psychiatry. 2022;27:1886\u201397.","journal-title":"Mol Psychiatry"},{"key":"2115_CR180","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1177\/0004867419893439","volume":"54","author":"CO Yolland","year":"2020","unstructured":"Yolland CO, Hanratty D, Neill E, Rossell SL, Berk M, Dean OM, et al. Meta-analysis of randomised controlled trials with N-acetylcysteine in the treatment of schizophrenia. Aust NZ J Psychiatry. 2020;54:453\u201366.","journal-title":"Aust NZ J Psychiatry"},{"key":"2115_CR181","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1111\/eip.12781","volume":"13","author":"SJ Schmidt","year":"2019","unstructured":"Schmidt SJ, Hurlemann R, Schultz J, Wasserthal S, Kloss C, Maier W, et al. Multimodal prevention of first psychotic episode through N-acetyl-l-cysteine and integrated preventive psychological intervention in individuals clinically at high risk for psychosis: Protocol of a randomized, placebo-controlled, parallel-group trial. Early Intervention Psychiatry. 2019;13:1404\u201315.","journal-title":"Early Intervention Psychiatry"},{"key":"2115_CR182","doi-asserted-by":"publisher","first-page":"2701","DOI":"10.1073\/pnas.1817885116","volume":"116","author":"TW Sedlak","year":"2019","unstructured":"Sedlak TW, Paul BD, Parker GM, Hester LD, Snowman AM, Taniguchi Y, et al. The glutathione cycle shapes synaptic glutamate activity. Proc Natl Acad Sci USA. 2019;116:2701\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2115_CR183","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1111\/eip.12988","volume":"15","author":"Z Li","year":"2021","unstructured":"Li Z, Zhang T, Xu L, Wei Y, Tang Y, Hu Q, et al. Decreasing risk of psychosis by sulforaphane study protocol for a randomized, double-blind, placebo-controlled, clinical multi-centre trial. Early Inter Psychiatry. 2021;15:585\u201394.","journal-title":"Early Inter Psychiatry"},{"key":"2115_CR184","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.cmet.2017.11.002","volume":"27","author":"J Yoshino","year":"2018","unstructured":"Yoshino J, Baur JA, Imai S-i. NAD+ intermediates: the biology and therapeutic potential of NMN and NR. Cell Metab. 2018;27:513\u201328.","journal-title":"Cell Metab"},{"key":"2115_CR185","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.schres.2017.02.024","volume":"187","author":"VA Chouinard","year":"2017","unstructured":"Chouinard VA, Kim SY, Valeri L, Yuksel C, Ryan KP, Chouinard G, et al. Brain bioenergetics and redox state measured by (31)P magnetic resonance spectroscopy in unaffected siblings of patients with psychotic disorders. Schizophr Res. 2017;187:11\u201316.","journal-title":"Schizophr Res"},{"key":"2115_CR186","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s13578-020-00491-3","volume":"10","author":"M Shayganfard","year":"2020","unstructured":"Shayganfard M. Molecular and biological functions of resveratrol in psychiatric disorders: a review of recent evidence. Cell Biosci. 2020;10:128.","journal-title":"Cell Biosci"},{"key":"2115_CR187","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/eip.13133","volume":"16","author":"SR Susai","year":"2022","unstructured":"Susai SR, Sabherwal S, Mongan D, Focking M, Cotter DR. Omega-3 fatty acid in ultra-high-risk psychosis: a systematic review based on functional outcome. Early Inter Psychiatry. 2022;16:3\u201316.","journal-title":"Early Inter Psychiatry"},{"key":"2115_CR188","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1111\/eip.13025","volume":"15","author":"A McLaverty","year":"2021","unstructured":"McLaverty A, Allott KA, Berger M, Hester R, McGorry PD, Nelson B, et al. Omega-3 fatty acids and neurocognitive ability in young people at ultra-high risk for psychosis. Early Intervention Psychiatry. 2021;15:874\u201381.","journal-title":"Early Intervention Psychiatry"},{"key":"2115_CR189","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1177\/070674371305800705","volume":"58","author":"GP Amminger","year":"2013","unstructured":"Amminger GP, Chanen AM, Ohmann S, Klier CM, Mossaheb N, Bechdolf A, et al. Omega-3 fatty acid supplementation in adolescents with borderline personality disorder and ultra-high risk criteria for psychosis: a post hoc subgroup analysis of a double-blind, randomized controlled trial. Can J Psychiatry. 2013;58:402\u20138.","journal-title":"Can J Psychiatry"},{"key":"2115_CR190","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2017.30","volume":"7","author":"S Lavoie","year":"2017","unstructured":"Lavoie S, Berger M, Schlogelhofer M, Schafer MR, Rice S, Kim SW, et al. Erythrocyte glutathione levels as long-term predictor of transition to psychosis. Transl Psychiatry. 2017;7:e1064.","journal-title":"Transl Psychiatry"},{"key":"2115_CR191","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1093\/schbul\/sbw003","volume":"42","author":"A Marconi","year":"2016","unstructured":"Marconi A, Di Forti M, Lewis CM, Murray RM, Vassos E. Meta-analysis of the association between the level of cannabis use and risk of psychosis. Schizophr Bull. 2016;42:1262\u20139.","journal-title":"Schizophr Bull"},{"key":"2115_CR192","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s00213-011-2566-z","volume":"221","author":"MM ElBatsh","year":"2012","unstructured":"ElBatsh MM, Assareh N, Marsden CA, Kendall DA. Anxiogenic-like effects of chronic cannabidiol administration in rats. Psychopharmacology. 2012;221:239\u201347.","journal-title":"Psychopharmacology"},{"key":"2115_CR193","first-page":"242","volume":"114","author":"T Demirakca","year":"2011","unstructured":"Demirakca T, Sartorius A, Ende G, Meyer N, Welzel H, Skopp G, et al. Diminished gray matter in the hippocampus of cannabis users: possible protective effects of cannabidiol. Drug Alcohol Depend. 2011;114:242\u20135.","journal-title":"Drug Alcohol Depend"},{"key":"2115_CR194","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1176\/appi.ajp.2017.17030325","volume":"175","author":"P McGuire","year":"2018","unstructured":"McGuire P, Robson P, Cubala WJ, Vasile D, Morrison PD, Barron R, et al. Cannabidiol (CBD) as an adjunctive therapy in schizophrenia: a multicenter randomized controlled trial. Am J Psychiatry. 2018;175:225\u201331.","journal-title":"Am J Psychiatry"},{"key":"2115_CR195","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/sj.bjp.0707133","volume":"150","author":"A Thomas","year":"2007","unstructured":"Thomas A, Baillie GL, Phillips AM, Razdan RK, Ross RA, Pertwee RG. Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro. Br J Pharmacol. 2007;150:613\u201323.","journal-title":"Br J Pharmacol"},{"key":"2115_CR196","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1038\/npp.2009.184","volume":"35","author":"S Bhattacharyya","year":"2010","unstructured":"Bhattacharyya S, Morrison PD, Fusar-Poli P, Martin-Santos R, Borgwardt S, Winton-Brown T, et al. Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology. Neuropsychopharmacology. 2010;35:764\u201374.","journal-title":"Neuropsychopharmacology"},{"key":"2115_CR197","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/S0306-4522(96)00428-9","volume":"77","author":"M Glass","year":"1997","unstructured":"Glass M, Dragunow M, Faull RL. Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain. Neuroscience. 1997;77:299\u2013318.","journal-title":"Neuroscience"},{"key":"2115_CR198","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.neuron.2016.03.034","volume":"90","author":"AV Stempel","year":"2016","unstructured":"Stempel AV, Stumpf A, Zhang HY, Ozdogan T, Pannasch U, Theis AK, et al. Cannabinoid type 2 receptors mediate a cell type-specific plasticity in the hippocampus. Neuron. 2016;90:795\u2013809.","journal-title":"Neuron"},{"key":"2115_CR199","doi-asserted-by":"publisher","first-page":"3239","DOI":"10.1046\/j.1460-9568.2000.00217.x","volume":"12","author":"N H\u00e1jos","year":"2000","unstructured":"H\u00e1jos N, Katona I, Naiem SS, Mackie K, Ledent C, Mody I, et al. Cannabinoids inhibit hippocampal GABAergic transmission and network oscillations. Eur J Neurosci. 2000;12:3239\u201349.","journal-title":"Eur J Neurosci"},{"key":"2115_CR200","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1038\/nn1801","volume":"9","author":"D Robbe","year":"2006","unstructured":"Robbe D, Montgomery SM, Thome A, Rueda-Orozco PE, McNaughton BL, Buzsaki G. Cannabinoids reveal importance of spike timing coordination in hippocampal function. Nat Neurosci. 2006;9:1526\u201333.","journal-title":"Nat Neurosci"},{"key":"2115_CR201","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/aps.2016.149","volume":"38","author":"DJ Chen","year":"2017","unstructured":"Chen DJ, Gao M, Gao FF, Su QX, Wu J. Brain cannabinoid receptor 2: expression, function and modulation. Acta Pharm Sin. 2017;38:312\u20136.","journal-title":"Acta Pharm Sin"},{"key":"2115_CR202","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1177\/0269881120936419","volume":"34","author":"MAP Bloomfield","year":"2020","unstructured":"Bloomfield MAP, Green SF, Hindocha C, Yamamori Y, Yim JLL, Jones APM, et al. The effects of acute cannabidiol on cerebral blood flow and its relationship to memory: an arterial spin labelling magnetic resonance imaging study. J Psychopharmacol. 2020;34:981\u20139.","journal-title":"J Psychopharmacol"},{"key":"2115_CR203","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1177\/0269881110379283","volume":"25","author":"JA Crippa","year":"2011","unstructured":"Crippa JA, Derenusson GN, Ferrari TB, Wichert-Ana L, Duran FL, Martin-Santos R, et al. Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report. J Psychopharmacol. 2011;25:121\u201330.","journal-title":"J Psychopharmacol"},{"key":"2115_CR204","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/sj.npp.1300340","volume":"29","author":"JADS Crippa","year":"2004","unstructured":"Crippa JADS, Zuardi AW, Garrido GEJ, Wichert-Ana L, Guarnieri R, Ferrari L, et al. Effects of cannabidiol (CBD) on regional cerebral blood flow. Neuropsychopharmacology. 2004;29:417\u201326.","journal-title":"Neuropsychopharmacology"},{"key":"2115_CR205","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1177\/0269881118805495","volume":"32","author":"A Viudez-Mart\u00ednez","year":"2018","unstructured":"Viudez-Mart\u00ednez A, Garc\u00eda-Guti\u00e9rrez MS, Manzanares J. Cannabidiol regulates the expression of hypothalamus-pituitary-adrenal axis-related genes in response to acute restraint stress. J Psychopharmacol. 2018;32:1379\u201384.","journal-title":"J Psychopharmacol"},{"key":"2115_CR206","doi-asserted-by":"publisher","first-page":"e94","DOI":"10.1038\/tp.2012.15","volume":"2","author":"FM Leweke","year":"2012","unstructured":"Leweke FM, Piomelli D, Pahlisch F, Muhl D, Gerth CW, Hoyer C, et al. Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia. Transl Psychiatry. 2012;2:e94\u2013e94.","journal-title":"Transl Psychiatry"},{"key":"2115_CR207","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.biopsych.2005.08.019","volume":"59","author":"ET Tzavara","year":"2006","unstructured":"Tzavara ET, Li DL, Moutsimilli L, Bisogno T, Di Marzo V, Phebus LA, et al. Endocannabinoids activate transient receptor potential vanilloid 1 receptors to reduce hyperdopaminergia-related hyperactivity: therapeutic implications. Biol Psychiatry. 2006;59:508\u201315.","journal-title":"Biol Psychiatry"},{"key":"2115_CR208","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1038\/sj.bjp.0707460","volume":"152","author":"E Ryberg","year":"2007","unstructured":"Ryberg E, Larsson N, Sj\u00f6gren S, Hjorth S, Hermansson N-O, Leonova J, et al. The orphan receptor GPR55 is a novel cannabinoid receptor. Br J Pharmacol. 2007;152:1092\u2013101.","journal-title":"Br J Pharmacol"},{"key":"2115_CR209","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1177\/02698811211001107","volume":"35","author":"A O\u2019Neill","year":"2021","unstructured":"O\u2019Neill A, Annibale L, Blest-Hopley G, Wilson R, Giampietro V, Bhattacharyya S. Cannabidiol modulation of hippocampal glutamate in early psychosis. J Psychopharmacol. 2021;35:814\u201322.","journal-title":"J Psychopharmacol"},{"key":"2115_CR210","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1001\/jamapsychiatry.2018.2309","volume":"75","author":"S Bhattacharyya","year":"2018","unstructured":"Bhattacharyya S, Wilson R, Appiah-Kusi E, O\u2019Neill A, Brammer M, Perez J, et al. Effect of cannabidiol on medial temporal, midbrain, and striatal dysfunction in people at clinical high risk of psychosis: a randomized clinical trial. JAMA Psychiatry. 2018;75:1107\u201317.","journal-title":"JAMA Psychiatry"},{"key":"2115_CR211","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1007\/s00213-019-05442-6","volume":"237","author":"E Appiah-Kusi","year":"2020","unstructured":"Appiah-Kusi E, Petros N, Wilson R, Colizzi M, Bossong MG, Valmaggia L, et al. Effects of short-term cannabidiol treatment on response to social stress in subjects at clinical high risk of developing psychosis. Psychopharmacology. 2020;237:1121\u201330.","journal-title":"Psychopharmacology"},{"key":"2115_CR212","doi-asserted-by":"publisher","first-page":"7679","DOI":"10.1038\/s41380-021-01198-8","volume":"26","author":"X Zhu","year":"2021","unstructured":"Zhu X, Cabungcal JH, Cuenod M, Uliana DL, Do KQ, Grace AA. Thalamic reticular nucleus impairments and abnormal prefrontal control of dopamine system in a developmental model of schizophrenia: prevention by N-acetylcysteine. Mol Psychiatry. 2021;26:7679\u201389.","journal-title":"Mol Psychiatry"},{"key":"2115_CR213","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1176\/appi.ajp.160.9.1627","volume":"160","author":"R Adrian","year":"2003","unstructured":"Adrian R, Kjetil M, Jianghong L, Peter V, Sarnoff A, Mednick. Effects of environmental enrichment at ages 3\u20135 years on schizotypal personality and antisocial behavior at ages 17 and 23 years. Am J Psychiatry. 2003;160:1627\u201335.","journal-title":"Am J Psychiatry"},{"key":"2115_CR214","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/S0272-7358(99)00032-X","volume":"21","author":"P Salmon","year":"2001","unstructured":"Salmon P. Effects of physical exercise on anxiety, depression, and sensitivity to stress: a unifying theory. Clin Psychol Rev. 2001;21:33\u201361.","journal-title":"Clin Psychol Rev"},{"key":"2115_CR215","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-89301-5","volume":"11","author":"KSF Damme","year":"2021","unstructured":"Damme KSF, Sloan RP, Bartels MN, Ozsan A, Ospina LH, Kimhy D, et al. Psychosis risk individuals show poor fitness and discrepancies with objective and subjective measures. Sci Rep. 2021;11:9851.","journal-title":"Sci Rep"},{"key":"2115_CR216","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.psychres.2014.08.052","volume":"220","author":"D Kimhy","year":"2014","unstructured":"Kimhy D, Vakhrusheva J, Bartels MN, Armstrong HF, Ballon JS, Khan S, et al. Aerobic fitness and body mass index in individuals with schizophrenia: implications for neurocognition and daily functioning. Psychiatry Res. 2014;220:784\u201391.","journal-title":"Psychiatry Res"},{"key":"2115_CR217","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.biopsych.2014.05.023","volume":"77","author":"TD Cannon","year":"2015","unstructured":"Cannon TD, Chung Y, He G, Sun D, Jacobson A, van Erp TG, et al. Progressive reduction in cortical thickness as psychosis develops: a multisite longitudinal neuroimaging study of youth at elevated clinical risk. Biol Psychiatry. 2015;77:147\u201357.","journal-title":"Biol Psychiatry"},{"key":"2115_CR218","doi-asserted-by":"publisher","DOI":"10.1038\/s41537-016-0007-z","volume":"3","author":"E Sormunen","year":"2017","unstructured":"Sormunen E, Saarinen MM, Salokangas RKR, Telama R, Hutri-K\u00e4h\u00f6nen N, Tammelin T, et al. Effects of childhood and adolescence physical activity patterns on psychosis risk\u2014a general population cohort study. npj Schizophrenia. 2017;3:5.","journal-title":"npj Schizophrenia"},{"key":"2115_CR219","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1093\/cercor\/bhz104","volume":"30","author":"JJ Steventon","year":"2019","unstructured":"Steventon JJ, Foster C, Furby H, Helme D, Wise RG, Murphy K. Hippocampal blood flow is increased after 20\u2009min of moderate-intensity exercise. Cereb Cortex. 2019;30:525\u201333.","journal-title":"Cereb Cortex"},{"key":"2115_CR220","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1111\/eip.12544","volume":"12","author":"J Firth","year":"2018","unstructured":"Firth J, Rosenbaum S, Ward PB, Curtis J, Teasdale SB, Yung AR, et al. Adjunctive nutrients in first-episode psychosis: a systematic review of efficacy, tolerability and neurobiological mechanisms. Early Inter Psychiatry. 2018;12:774\u201383.","journal-title":"Early Inter Psychiatry"},{"key":"2115_CR221","doi-asserted-by":"publisher","first-page":"3017","DOI":"10.1073\/pnas.1015950108","volume":"108","author":"KI Erickson","year":"2011","unstructured":"Erickson KI, Voss MW, Prakash RS, Basak C, Szabo A, Chaddock L, et al. Exercise training increases size of hippocampus and improves memory. Proc Natl Acad Sci USA. 2011;108:3017\u201322.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2115_CR222","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1017\/S0033291714003110","volume":"45","author":"J Firth","year":"2015","unstructured":"Firth J, Cotter J, Elliott R, French P, Yung AR. A systematic review and meta-analysis of exercise interventions in schizophrenia patients. Psychological Med. 2015;45:1343\u201361.","journal-title":"Psychological Med"},{"key":"2115_CR223","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1016\/j.nicl.2018.10.021","volume":"20","author":"M McHugo","year":"2018","unstructured":"McHugo M, Talati P, Woodward ND, Armstrong K, Blackford JU, Heckers S. Regionally specific volume deficits along the hippocampal long axis in early and chronic psychosis. Neuroimage Clin. 2018;20:1106\u201314.","journal-title":"Neuroimage Clin"},{"key":"2115_CR224","doi-asserted-by":"crossref","unstructured":"Damme KSF, Gupta T, Ristanovic I, Kimhy D, Bryan AD, Mittal VA. Exercise intervention in individuals at clinical high risk for psychosis: benefits to fitness, symptoms, hippocampal volumes, and functional connectivity. Schizophr Bull. 2022;sbac084.","DOI":"10.1093\/schbul\/sbac084"},{"key":"2115_CR225","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1089\/ars.2011.4498","volume":"18","author":"Z Radak","year":"2013","unstructured":"Radak Z, Radak ZZ, Koltai E, Ohno H, Atalay M. Oxygen consumption and usage during physical exercise: the balance between oxidative stress and ROS-dependent adaptive signaling. Antioxid Redox Signal. 2013;18:1208\u201346.","journal-title":"Antioxid Redox Signal"},{"key":"2115_CR226","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s00406-020-01200-4","volume":"271","author":"G Bang-Kittilsen","year":"2021","unstructured":"Bang-Kittilsen G, Egeland J, Holmen TL, Bigseth TT, Andersen E, Mordal J, et al. High-intensity interval training and active video gaming improve neurocognition in schizophrenia: a randomized controlled trial. Eur Arch Psychiatry Clin Neurosci. 2021;271:339\u201353.","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"2115_CR227","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1017\/S0033291717001945","volume":"48","author":"M Rus-Calafell","year":"2018","unstructured":"Rus-Calafell M, Garety P, Sason E, Craig TJK, Valmaggia LR. Virtual reality in the assessment and treatment of psychosis: a systematic review of its utility, acceptability and effectiveness. Psychological Med. 2018;48:362\u201391.","journal-title":"Psychological Med"},{"key":"2115_CR228","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/nrn3155","volume":"13","author":"O Marin","year":"2012","unstructured":"Marin O. Interneuron dysfunction in psychiatric disorders. Nat Rev Neurosci. 2012;13:107\u201320.","journal-title":"Nat Rev Neurosci"},{"key":"2115_CR229","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3390\/ijms21228704","volume":"21","author":"K Govindpani","year":"2020","unstructured":"Govindpani K, Turner C, Waldvogel HJ, Faull RLM, Kwakowsky A. Impaired expression of GABA signaling components in the Alzheimer's disease middle temporal gyrus. Int J Mol Sci. 2020;21:22.","journal-title":"Int J Mol Sci"},{"key":"2115_CR230","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1001\/jamapsychiatry.2022.1163","volume":"79","author":"DB Dwyer","year":"2022","unstructured":"Dwyer DB, Buciuman MO, Ruef A, Kambeitz J, Sen Dong M, Stinson C, et al. Clinical, brain, and multilevel clustering in early psychosis and affective stages. JAMA Psychiatry. 2022;79:677\u201389.","journal-title":"JAMA Psychiatry"},{"key":"2115_CR231","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1093\/schbul\/sbab037","volume":"47","author":"F Stein","year":"2021","unstructured":"Stein F, Meller T, Brosch K, Schmitt S, Ringwald K, Pfarr JK, et al. Psychopathological syndromes across affective and psychotic disorders correlate with gray matter volumes. Schizophr Bull. 2021;47:1740\u201350.","journal-title":"Schizophr Bull"},{"key":"2115_CR232","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1038\/s41380-019-0441-1","volume":"24","author":"AF Marquand","year":"2019","unstructured":"Marquand AF, Kia SM, Zabihi M, Wolfers T, Buitelaar JK, Beckmann CF. Conceptualizing mental disorders as deviations from normative functioning. Mol Psychiatry. 2019;24:1415\u201324.","journal-title":"Mol Psychiatry"},{"key":"2115_CR233","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.biopsych.2020.07.012","volume":"89","author":"AM Dickens","year":"2021","unstructured":"Dickens AM, Sen P, Kempton MJ, Barrantes-Vidal N, Iyegbe C, Nordentoft M, et al. Dysregulated lipid metabolism precedes onset of psychosis. Biol Psychiatry. 2021;89:288\u201397.","journal-title":"Biol Psychiatry"},{"key":"2115_CR234","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1002\/hbm.25234","volume":"42","author":"LEM Wisse","year":"2021","unstructured":"Wisse LEM, Chetelat G, Daugherty AM, de Flores R, la Joie R, Mueller SG, et al. Hippocampal subfield volumetry from structural isotropic 1 mm(3) MRI scans: a note of caution. Hum Brain Mapp. 2021;42:539\u201350.","journal-title":"Hum Brain Mapp"},{"key":"2115_CR235","doi-asserted-by":"publisher","first-page":"e60514","DOI":"10.1371\/journal.pone.0060514","volume":"8","author":"F De Martino","year":"2013","unstructured":"De Martino F, Zimmermann J, Muckli L, Ugurbil K, Yacoub E, Goebel R. Cortical depth dependent functional responses in humans at 7T: improved specificity with 3D GRASE. PLoS One. 2013;8:e60514.","journal-title":"PLoS One"},{"key":"2115_CR236","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1002\/mrm.24156","volume":"68","author":"RM Heidemann","year":"2012","unstructured":"Heidemann RM, Ivanov D, Trampel R, Fasano F, Meyer H, Pfeuffer J, et al. Isotropic submillimeter fMRI in the human brain at 7 T: combining reduced field-of-view imaging and partially parallel acquisitions. Magn Reson Med. 2012;68:1506\u201316.","journal-title":"Magn Reson Med"},{"key":"2115_CR237","doi-asserted-by":"publisher","first-page":"116192","DOI":"10.1016\/j.neuroimage.2019.116192","volume":"203","author":"DN Barry","year":"2019","unstructured":"Barry DN, Tierney TM, Holmes N, Boto E, Roberts G, Leggett J, et al. Imaging the human hippocampus with optically-pumped magnetoencephalography. Neuroimage. 2019;203:116192.","journal-title":"Neuroimage"},{"key":"2115_CR238","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s40658-016-0155-2","volume":"3","author":"B Wu","year":"2016","unstructured":"Wu B, Warnock G, Zaiss M, Lin C, Chen M, Zhou Z, et al. An overview of CEST MRI for non-MR physicists. EJNMMI Phys. 2016;3:19.","journal-title":"EJNMMI Phys"},{"key":"2115_CR239","doi-asserted-by":"publisher","first-page":"611014","DOI":"10.3389\/fcimb.2020.611014","volume":"10","author":"W Tang","year":"2020","unstructured":"Tang W, Meng Z, Li N, Liu Y, Li L, Chen D, et al. Roles of gut microbiota in the regulation of hippocampal plasticity, inflammation, and hippocampus-dependent behaviors. Front Cell Infect Microbiol. 2020;10:611014.","journal-title":"Front Cell Infect Microbiol"},{"key":"2115_CR240","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-96138-5","volume":"11","author":"G Olivo","year":"2021","unstructured":"Olivo G, Nilsson J, Garzon B, Lebedev A, Wahlin A, Tarassova O, et al. Higher VO2max is associated with thicker cortex and lower grey matter blood flow in older adults. Sci Rep. 2021;11:16724.","journal-title":"Sci Rep"},{"key":"2115_CR241","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1002\/hipo.23166","volume":"30","author":"RK Nauer","year":"2020","unstructured":"Nauer RK, Dunne MF, Stern CE, Storer TW, Schon K. Improving fitness increases dentate gyrus\/CA3 volume in the hippocampal head and enhances memory in young adults. Hippocampus. 2020;30:488\u2013504.","journal-title":"Hippocampus"},{"key":"2115_CR242","doi-asserted-by":"publisher","first-page":"3127","DOI":"10.1002\/cne.24080","volume":"524","author":"S-L Ding","year":"2016","unstructured":"Ding S-L, Royall JJ, Sunkin SM, Ng L, Facer BAC, Lesnar P, et al. Comprehensive cellular-resolution atlas of the adult human brain. J Comp Neurol. 2016;524:3127\u2013481.","journal-title":"J Comp Neurol"},{"key":"2115_CR243","doi-asserted-by":"publisher","first-page":"117878","DOI":"10.1016\/j.neuroimage.2021.117878","volume":"232","author":"M Norgaard","year":"2021","unstructured":"Norgaard M, Beliveau V, Ganz M, Svarer C, Pinborg LH, Keller SH, et al. A high-resolution in vivo atlas of the human brain\u2019s benzodiazepine binding site of GABAA receptors. Neuroimage. 2021;232:117878.","journal-title":"Neuroimage"},{"key":"2115_CR244","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s00429-005-0025-5","volume":"210","author":"K Amunts","year":"2005","unstructured":"Amunts K, Kedo O, Kindler M, Pieperhoff P, Mohlberg H, Shah NJ, et al. Cytoarchitectonic mapping of the human amygdala, hippocampal region and entorhinal cortex: intersubject variability and probability maps. Anat Embryol. 2005;210:343\u201352.","journal-title":"Anat Embryol"},{"key":"2115_CR245","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.neuroscience.2013.05.061","volume":"248","author":"R Khalaf-Nazzal","year":"2013","unstructured":"Khalaf-Nazzal R, Francis F. Hippocampal development\u2014old and new findings. Neuroscience. 2013;248:225\u201342.","journal-title":"Neuroscience"},{"key":"2115_CR246","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.neuron.2009.11.031","volume":"65","author":"MS Fanselow","year":"2010","unstructured":"Fanselow MS, Dong HW. Are the dorsal and ventral hippocampus functionally distinct structures? Neuron. 2010;65:7\u201319.","journal-title":"Neuron"},{"key":"2115_CR247","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/npp.2009.93","volume":"35","author":"SR Sesack","year":"2010","unstructured":"Sesack SR, Grace AA. Cortico-Basal Ganglia reward network: microcircuitry. Neuropsychopharmacology. 2010;35:27\u201347.","journal-title":"Neuropsychopharmacology"},{"key":"2115_CR248","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1001\/jamapsychiatry.2019.3360","volume":"77","author":"RA McCutcheon","year":"2020","unstructured":"McCutcheon RA, Reis Marques T, Howes OD. Schizophrenia\u2014an overview. JAMA Psychiatry. 2020;77:201\u201310.","journal-title":"JAMA Psychiatry"}],"updated-by":[{"DOI":"10.1038\/s41398-022-02154-y","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2022,9,12]],"date-time":"2022-09-12T00:00:00Z","timestamp":1662940800000}}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41398-022-02115-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-022-02115-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-022-02115-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,22]],"date-time":"2022-10-22T23:04:27Z","timestamp":1666479867000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41398-022-02115-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,25]]},"references-count":248,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2115"],"URL":"https:\/\/doi.org\/10.1038\/s41398-022-02115-5","relation":{"correction":[{"id-type":"doi","id":"10.1038\/s41398-022-02154-y","asserted-by":"object"}]},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,25]]},"assertion":[{"value":"1 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2022","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41398-022-02154-y","URL":"https:\/\/doi.org\/10.1038\/s41398-022-02154-y","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"AAG has received consulting fees from Alkermes, Lundbeck, Takeda, Roche, Lyra, Concert, and SynAgile. RM has received honoraria from Janssen and Otsuka. The other authors declare no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"344"}}